Lightwave Logic (LWLG) 10-K31 Mar 142013 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Dec. 31, 2013	Mar. 31, 2014	Jun. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'Lightwave Logic, Inc.	'	'
Entity Central Index Key	'0001325964	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Amendment Flag	'false	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$38,193,179
Entity Common Stock, Shares Outstanding	'	53,080,469	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2013	'	'

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Jun. 30, 2013	Dec. 31, 2012
CURRENT ASSETS	'	'
Cash and cash equivalents	$2,270,704	$2,936,879
Prepaid expenses and other current assets	132,204	89,975
Total Current Assets	2,402,908	3,026,854
PROPERTY AND EQUIPMENT - NET	298,360	300,994
OTHER ASSETS	'	'
Intangible assets - net	543,540	488,526
TOTAL ASSETS	3,244,808	3,816,374
CURRENT LIABILITIES	'	'
Accounts payable	65,410	96,384
Accounts payable and accrued expenses- related parties	48,817	55,606
Accrued expenses	7,949	3,338
TOTAL LIABILITIES	122,176	155,328
STOCKHOLDERS' EQUITY	'	'
Preferred stock, $0.001 par value, 1,000,000 authorized no shares issued or outstanding	'	'
Common stock $0.001 par value, 100,000,000 authorized 52,617,789 and 50,160,758 issued and outstanding at December 31, 2013 and December 31, 2012	52,618	50,161
Additional paid-in capital	35,414,206	32,042,751
Accumulated deficit	-15,827	-15,827
Deficit accumulated during development stage	-32,328,365	-28,416,039
TOTAL STOCKHOLDERS' EQUITY	3,122,632	3,661,046
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$3,244,808	$3,816,374

BALANCE_SHEETS_Parenthetical

BALANCE SHEETS (Parenthetical) (USD $)	Jun. 30, 2013	Dec. 31, 2012
BALANCE SHEETS [Abstract]	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	52,617,789	50,160,758
Common stock, shares outstanding	52,617,789	50,160,758

STATEMENTS_OF_OPERATIONS

STATEMENTS OF OPERATIONS (USD $)	12 Months Ended		120 Months Ended
STATEMENTS OF OPERATIONS (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
STATEMENTS OF OPERATIONS [Abstract]	'	'	'
NET SALES	'	'	$3,200
COST AND EXPENSE	'	'	'
Research and development	2,068,050	2,489,747	15,222,238
General and administrative	1,632,387	1,936,417	16,553,954
TOTAL COST AND EXPENSE	3,700,437	4,426,164	31,776,192
LOSS FROM OPERATIONS	-3,700,437	-4,426,164	-31,772,992
OTHER INCOME (EXPENSE)	'	'	'
Interest income	267	548	31,313
Dividend income	'	'	1,551
Realized gain on investment	'	'	3,911
Realized gain on disposal of assets	'	'	637
Litigation settlement	'	'	-47,500
Commitment fee and Interest expense	-212,156	-130,922	-545,285
NET LOSS	($3,912,326)	($4,556,538)	($32,328,365)
Basic and Diluted Loss per Share	($0.08)	($0.09)	'
Basic and Diluted Weighted Average Number of Shares	51,672,177	48,778,783	'

STATEMENT_OF_STOCKHOLDERS_EQUI

STATEMENT OF STOCKHOLDERS' EQUITY (USD $)	Total	Common Stock [Member]	Paid-in Capital [Member]	Subscription Receivable / Receivable for Issuance of Common Stock [Member]	Deferred Charges [Member]	Unrealized Loss on Securities [Member]	Accumulated Deficit [Member]	Deficit Accumulated During Development Stage [Member]
Balance at Dec. 31, 2002	($15,826)	$1	'	'	'	'	($15,827)	'
Balance, shares at Dec. 31, 2002	'	100	'	'	'	'	'	'
Retroactive recapitalization upon reverse acquisition	'	706	-706	'	'	'	'	'
Retroactive recapitalization upon reverse acquisition, shares	'	706,973	'	'	'	'	'	'
Balance at Dec. 31, 2003	-15,826	707	-706	'	'	'	-15,827	'
Balance, shares at Dec. 31, 2003	'	707,073	'	'	'	'	'	'
Common stock issued to founders	'	13,293	-13,293	'	'	'	'	'
Common stock issued to founders, shares	'	13,292,927	'	'	'	'	'	'
Common stock issued for future services transaction one	256,000	1,600	254,400	'	'	'	'	'
Common stock issued for future services transaction one, shares	'	1,600,000	'	'	'	'	'	'
Common stock issued for future services transaction two	75,000	638	74,362	'	'	'	'	'
Common stock issued for future services transaction two, shares	'	637,500	'	'	'	'	'	'
Common stock issued at merger	'	2,000	-2,000	'	'	'	'	'
Common stock issued at merger, shares	'	2,000,000	'	'	'	'	'	'
Conversion of notes payable	30,000	187	29,813	'	'	'	'	'
Conversion of notes payable, shares	'	187,500	'	'	'	'	'	'
Net loss	-722,146	'	'	'	'	'	'	-722,146
Balance at Dec. 31, 2004	-376,972	18,425	342,576	'	'	'	-15,827	-722,146
Balance, shares at Dec. 31, 2004	'	18,425,000	'	'	'	'	'	'
Common stock issued for future services transaction one	585,500	210	585,290	'	'	'	'	'
Common stock issued for future services transaction one, shares	'	210,000	'	'	'	'	'	'
Common stock issued for future services transaction two	584,000	200	583,800	'	'	'	'	'
Common stock issued for future services transaction two, shares	'	200,000	'	'	'	'	'	'
Common stock issued in private placement transaction one	1,000,000	4,000	996,000	'	'	'	'	'
Common stock issued in private placement transaction one, shares	'	4,000,000	'	'	'	'	'	'
Conversion of notes payable	499,000	3,119	495,881	'	'	'	'	'
Conversion of notes payable, shares	'	3,118,750	'	'	'	'	'	'
Subscription receivable	-6,500	'	'	-6,500	'	'	'	'
Warrants issued for services transaction one	37,000	'	37,000	'	'	'	'	'
Warrants issued for services transaction two	24,200	'	24,200	'	'	'	'	'
Warrants issued for services transaction three	15,900	'	15,900	'	'	'	'	'
Warrants issued for future services	435,060	'	435,060	'	'	'	'	'
Exercise of warrants transaction one	75,000	300	74,700	'	'	'	'	'
Exercise of warrants transaction one, shares	'	300,000	'	'	'	'	'	'
Deferred charges for common stock issued for future services	-584,000	'	'	'	-584,000	'	'	'
Amortization of deferred charges	265,455	'	'	'	265,455	'	'	'
Net loss	-1,721,765	'	'	'	'	'	'	-1,721,765
Balance at Dec. 31, 2005	831,878	26,254	3,590,407	-6,500	-318,545	'	-15,827	-2,443,911
Balance, shares at Dec. 31, 2005	'	26,253,750	'	'	'	'	'	'
Common stock issued for future services transaction one	270,000	300	269,700	'	'	'	'	'
Common stock issued for future services transaction one, shares	'	300,000	'	'	'	'	'	'
Common stock issued for future services transaction two	620,000	400	619,600	'	'	'	'	'
Common stock issued for future services transaction two, shares	'	400,000	'	'	'	'	'	'
Common stock issued for future services transaction three	36,250	25	36,225	'	'	'	'	'
Common stock issued for future services transaction three, shares	'	25,000	'	'	'	'	'	'
Common stock issued for future services transaction four	29,400	60	29,340	'	'	'	'	'
Common stock issued for future services transaction four, shares	'	60,000	'	'	'	'	'	'
Common stock issued in private placement transaction one	425,000	850	424,150	'	'	'	'	'
Common stock issued in private placement transaction one, shares	'	850,000	'	'	'	'	'	'
Contributed capital related to accrued interest	35,624	'	35,624	'	'	'	'	'
Subscription receivable	6,500	'	'	6,500	'	'	'	'
Warrants issued for services transaction one	66,500	'	66,500	'	'	'	'	'
Warrants issued for future services	465,996	'	465,996	'	'	'	'	'
Options issued for services transaction one	428,888	'	428,888	'	'	'	'	'
Amortization of deferred charges	318,545	'	'	'	318,545	'	'	'
Unrealized gain (loss) on securities	-26,000	'	'	'	'	-26,000	'	'
Net loss	-2,933,809	'	'	'	'	'	'	-2,933,809
Balance at Dec. 31, 2006	574,772	27,889	5,966,430	'	'	-26,000	-15,827	-5,377,720
Balance, shares at Dec. 31, 2006	'	27,888,750	'	'	'	'	'	'
Balance at Dec. 31, 2009	746,988	41,167	17,385,295	'	'	'	-15,827	-16,663,647
Balance, shares at Dec. 31, 2009	'	41,166,542	'	'	'	'	'	'
Common stock issued in private placement transaction one	1,500,000	1,500	1,498,500	'	'	'	'	'
Common stock issued in private placement transaction one, shares	'	1,500,000	'	'	'	'	'	'
Common stock issued for services transaction one	6,000	4	5,996	'	'	'	'	'
Common stock issued for services transaction one, shares	'	4,800	'	'	'	'	'	'
Common stock issued for services transaction two	4,650	5	4,645	'	'	'	'	'
Common stock issued for services transaction two, shares	'	5,000	'	'	'	'	'	'
Common stock issued for services transaction three	12,000	10	11,990	'	'	'	'	'
Common stock issued for services transaction three, shares	'	10,000	'	'	'	'	'	'
Warrants issued for services transaction one	213,459	'	213,459	'	'	'	'	'
Warrants issued for services transaction two	580,167	'	580,167	'	'	'	'	'
Warrants issued for services transaction three	214,063	'	214,063	'	'	'	'	'
Exercise of warrants transaction one	236,800	947	235,853	'	'	'	'	'
Exercise of warrants transaction one, shares	'	947,200	'	'	'	'	'	'
Exercise of warrants transaction two	3,450	10	3,440	'	'	'	'	'
Exercise of warrants transaction two, shares	'	10,000	'	'	'	'	'	'
Exercise of warrants transaction three	12,500	25	12,475	'	'	'	'	'
Exercise of warrants transaction three, shares	'	25,000	'	'	'	'	'	'
Exercise of warrants transaction four	282,500	283	282,218	'	'	'	'	'
Exercise of warrants transaction four, shares	'	282,500	'	'	'	'	'	'
Exercise of options	3,750	15	3,735	'	'	'	'	'
Exercised	'	15,000	'	'	'	'	'	'
Options issued for services transaction one	174,866	'	174,866	'	'	'	'	'
Options issued for services transaction two	14,873	'	14,873	'	'	'	'	'
Options issued for services transaction three	74,061	'	74,061	'	'	'	'	'
Options issued for services transaction four	643,812	'	643,812	'	'	'	'	'
Options issued for services transaction five	31,478	'	31,478	'	'	'	'	'
Options issued for services transaction six	27,434	'	27,434	'	'	'	'	'
Options issued for services transaction seven	286,002	'	286,002	'	'	'	'	'
Net loss	-3,713,232	'	'	'	'	'	'	-3,713,232
Balance at Dec. 31, 2010	1,355,621	43,966	21,704,361	'	'	'	-15,827	-20,376,879
Balance, shares at Dec. 31, 2010	'	43,966,042	'	'	'	'	'	'
Common stock issued in private placement transaction one	1,000,000	1,000	999,000	'	'	'	'	'
Common stock issued in private placement transaction one, shares	'	1,000,000	'	'	'	'	'	'
Common stock issued for services transaction one	14,500	10	14,490	'	'	'	'	'
Common stock issued for services transaction one, shares	'	10,000	'	'	'	'	'	'
Common stock issued for services transaction two	10,400	10	10,390	'	'	'	'	'
Common stock issued for services transaction two, shares	'	10,000	'	'	'	'	'	'
Common stock issued for services transaction three	14,500	10	14,490	'	'	'	'	'
Common stock issued for services transaction three, shares	'	10,000	'	'	'	'	'	'
Common stock issued for services transaction four	2,163	2	2,161	'	'	'	'	'
Common stock issued for services transaction four, shares	'	2,018	'	'	'	'	'	'
Common stock issued for commitment shares	162,896	151	162,746	'	'	'	'	'
Common stock issued for commitment shares, shares	'	150,830	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction one	3,470	3	3,467	'	'	'	'	'
Common stock issued for additional commitment shares transaction one, shares	'	3,017	'	'	'	'	'	'
Common stock issued to institutional investor transaction one	200,000	185	199,815	'	'	'	'	'
Common stock issued to institutional investor transaction one, shares	'	185,185	'	'	'	'	'	'
Warrants issued for services transaction one	306,765	'	306,765	'	'	'	'	'
Warrants issued for services transaction two	64,983	'	64,983	'	'	'	'	'
Warrants issued for services transaction three	36,585	'	36,585	'	'	'	'	'
Warrants issued for services transaction four	109,820	'	109,820	'	'	'	'	'
Warrants issued for services transaction five	1,288	'	1,288	'	'	'	'	'
Options issued for services transaction one	285	'	285	'	'	'	'	'
Options issued for services transaction two	39,829	'	39,829	'	'	'	'	'
Options issued for services transaction three	383,881	'	383,881	'	'	'	'	'
Options issued for services transaction four	26,648	'	26,648	'	'	'	'	'
Options issued for services transaction five	65,447	'	65,447	'	'	'	'	'
Options issued for services transaction six	212,136	'	212,136	'	'	'	'	'
Options issued for services transaction seven	79,702	'	79,702	'	'	'	'	'
Options issued for services transaction eight	17,204	'	17,204	'	'	'	'	'
Options issued for services transaction nine	4,384	'	4,384	'	'	'	'	'
Options issued for services transaction ten	53,124	'	53,124	'	'	'	'	'
Net loss	-3,482,622	'	'	'	'	'	'	-3,482,622
Balance at Dec. 31, 2011	683,009	45,337	24,513,000	'	'	'	-15,827	-23,859,501
Balance, shares at Dec. 31, 2011	'	45,337,092	'	'	'	'	'	'
Common stock issued for services transaction one	1,607	1	1,606	'	'	'	'	'
Common stock issued for services transaction one, shares	'	1,406	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction one	4,948	3	4,945	'	'	'	'	'
Common stock issued for additional commitment shares transaction one, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction two	5,038	3	5,035	'	'	'	'	'
Common stock issued for additional commitment shares transaction two, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction three	21,645	7	21,638	'	'	'	'	'
Common stock issued for additional commitment shares transaction three, shares	'	7,542	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction four	5,943	3	5,940	'	'	'	'	'
Common stock issued for additional commitment shares transaction four, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction five	11,765	5	11,760	'	'	'	'	'
Common stock issued for additional commitment shares transaction five, shares	'	4,525	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction six	7,965	3	7,962	'	'	'	'	'
Common stock issued for additional commitment shares transaction six, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction seven	6,728	3	6,725	'	'	'	'	'
Common stock issued for additional commitment shares transaction seven, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction eight	5,431	3	5,428	'	'	'	'	'
Common stock issued for additional commitment shares transaction eight, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction nine	5,672	3	5,669	'	'	'	'	'
Common stock issued for additional commitment shares transaction nine, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction ten	5,793	3	5,790	'	'	'	'	'
Common stock issued for additional commitment shares transaction ten, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction eleven	4,827	3	4,824	'	'	'	'	'
Common stock issued for additional commitment shares transaction eleven, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction twelve	5,823	3	5,820	'	'	'	'	'
Common stock issued for additional commitment shares transaction twelve, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction thirteen	10,258	6	10,252	'	'	'	'	'
Common stock issued for additional commitment shares transaction thirteen, shares	'	6,034	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction fourteen	4,073	3	4,070	'	'	'	'	'
Common stock issued for additional commitment shares transaction fourteen, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction fifteen	3,862	3	3,859	'	'	'	'	'
Common stock issued for additional commitment shares transaction fifteen, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction sixteen	3,862	3	3,859	'	'	'	'	'
Common stock issued for additional commitment shares transaction sixteen, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction seventeen	3,560	3	3,557	'	'	'	'	'
Common stock issued for additional commitment shares transaction seventeen, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction eighteen	3,258	3	3,255	'	'	'	'	'
Common stock issued for additional commitment shares transaction eighteen, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction nineteen	3,289	3	3,286	'	'	'	'	'
Common stock issued for additional commitment shares transaction nineteen, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction twenty	1,568	2	1,566	'	'	'	'	'
Common stock issued for additional commitment shares transaction twenty, shares	'	1,508	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction twenty-one	2,488	2	2,486	'	'	'	'	'
Common stock issued for additional commitment shares transaction twenty-one, shares	'	2,262	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction twenty-two	3,017	3	3,014	'	'	'	'	'
Common stock issued for additional commitment shares transaction twenty-two, shares	'	3,017	'	'	'	'	'	'
Common stock issued to institutional investor transaction one	200,000	198	199,802	'	'	'	'	'
Common stock issued to institutional investor transaction one, shares	'	197,433	'	'	'	'	'	'
Common stock issued to institutional investor transaction two	199,999	167	199,832	'	'	'	'	'
Common stock issued to institutional investor transaction two, shares	'	167,084	'	'	'	'	'	'
Common stock issued to institutional investor transaction three	499,999	317	499,682	'	'	'	'	'
Common stock issued to institutional investor transaction three, shares	'	316,455	'	'	'	'	'	'
Common stock issued to institutional investor transaction four	200,000	120	199,880	'	'	'	'	'
Common stock issued to institutional investor transaction four, shares	'	120,482	'	'	'	'	'	'
Common stock issued to institutional investor transaction five	299,999	158	299,841	'	'	'	'	'
Common stock issued to institutional investor transaction five, shares	'	158,144	'	'	'	'	'	'
Common stock issued to institutional investor transaction six	200,001	97	199,904	'	'	'	'	'
Common stock issued to institutional investor transaction six, shares	'	96,479	'	'	'	'	'	'
Common stock issued to institutional investor transaction seven	200,000	92	199,908	'	'	'	'	'
Common stock issued to institutional investor transaction seven, shares	'	91,324	'	'	'	'	'	'
Common stock issued to institutional investor transaction eight	200,001	119	199,882	'	'	'	'	'
Common stock issued to institutional investor transaction eight, shares	'	119,048	'	'	'	'	'	'
Common stock issued to institutional investor transaction nine	399,999	221	399,778	'	'	'	'	'
Common stock issued to institutional investor transaction nine, shares	'	220,994	'	'	'	'	'	'
Common stock issued to institutional investor transaction ten	200,001	131	199,870	'	'	'	'	'
Common stock issued to institutional investor transaction ten, shares	'	130,719	'	'	'	'	'	'
Common stock issued to institutional investor transaction eleven	200,000	120	199,880	'	'	'	'	'
Common stock issued to institutional investor transaction eleven, shares	'	119,976	'	'	'	'	'	'
Common stock issued to institutional investor transaction twelve	199,999	132	199,867	'	'	'	'	'
Common stock issued to institutional investor transaction twelve, shares	'	132,450	'	'	'	'	'	'
Common stock issued to institutional investor transaction thirteen	200,001	119	199,882	'	'	'	'	'
Common stock issued to institutional investor transaction thirteen, shares	'	119,261	'	'	'	'	'	'
Common stock issued to institutional investor transaction fourteen	200,000	177	199,823	'	'	'	'	'
Common stock issued to institutional investor transaction fourteen, shares	'	176,991	'	'	'	'	'	'
Common stock issued to institutional investor transaction fifteen	200,001	178	199,823	'	'	'	'	'
Common stock issued to institutional investor transaction fifteen, shares	'	177,510	'	'	'	'	'	'
Common stock issued to institutional investor transaction sixteen	200,000	180	199,820	'	'	'	'	'
Common stock issued to institutional investor transaction sixteen, shares	'	180,668	'	'	'	'	'	'
Common stock issued to institutional investor transaction seventeen	200,000	182	199,818	'	'	'	'	'
Common stock issued to institutional investor transaction seventeen, shares	'	181,818	'	'	'	'	'	'
Common stock issued to institutional investor transaction eighteen	200,000	188	199,812	'	'	'	'	'
Common stock issued to institutional investor transaction eighteen, shares	'	188,147	'	'	'	'	'	'
Common stock issued to institutional investor transaction nineteen	199,999	196	199,803	'	'	'	'	'
Common stock issued to institutional investor transaction nineteen, shares	'	196,078	'	'	'	'	'	'
Common stock issued to institutional investor transaction twenty	100,000	98	99,902	'	'	'	'	'
Common stock issued to institutional investor transaction twenty, shares	'	98,039	'	'	'	'	'	'
Common stock issued to institutional investor transaction twenty-one	350,000	350	349,650	'	'	'	'	'
Common stock issued to institutional investor transaction twenty-one, shares	'	350,000	'	'	'	'	'	'
Warrants issued for services transaction one	36,605	'	36,605	'	'	'	'	'
Warrants issued for services transaction two	157,127	'	157,127	'	'	'	'	'
Warrants issued for services transaction three	13,709	'	13,709	'	'	'	'	'
Warrants issued for services transaction four	55,648	'	55,648	'	'	'	'	'
Warrants issued for services transaction five	28,237	'	28,237	'	'	'	'	'
Exercise of warrants transaction one	50,000	40	49,960	'	'	'	'	'
Exercise of warrants transaction one, shares	'	40,000	'	'	'	'	'	'
Exercise of warrants transaction two	6,900	20	6,880	'	'	'	'	'
Exercise of warrants transaction two, shares	'	20,000	'	'	'	'	'	'
Exercise of warrants transaction three	225,000	900	224,100	'	'	'	'	'
Exercise of warrants transaction three, shares	'	900,000	'	'	'	'	'	'
Exercise of options	162,500	250	162,250	'	'	'	'	'
Exercised	'	250,000	'	'	'	'	'	'
Options issued for services transaction one	38,194	'	38,194	'	'	'	'	'
Options issued for services transaction two	85,290	'	85,290	'	'	'	'	'
Options issued for services transaction three	48,510	'	48,510	'	'	'	'	'
Options issued for services transaction four	41,156	'	41,156	'	'	'	'	'
Options issued for services transaction five	26,304	'	26,304	'	'	'	'	'
Options issued for services transaction six	51,392	'	51,392	'	'	'	'	'
Options issued for services transaction seven	139,755	'	139,755	'	'	'	'	'
Options issued for services transaction eight	42,227	'	42,227	'	'	'	'	'
Options issued for services transaction nine	462,455	'	462,455	'	'	'	'	'
Options issued for services transaction ten	56,568	'	56,568	'	'	'	'	'
Options issued for services transaction eleven	15,611	'	15,611	'	'	'	'	'
Options issued for services transaction twelve	7,137	'	7,137	'	'	'	'	'
Options issued for services transaction thirteen	266,710	'	266,710	'	'	'	'	'
Options issued for services transaction fourteen	25,420	'	25,420	'	'	'	'	'
Options issued for services transaction fifteen	60,283	'	60,283	'	'	'	'	'
Options issued for services transaction sixteen	309,049	'	309,049	'	'	'	'	'
Options issued for services transaction seventeen	29,375	'	29,375	'	'	'	'	'
Options issued for services transaction eighteen	39,270	'	39,270	'	'	'	'	'
Options issued for services transaction nineteen	29,529	'	29,529	'	'	'	'	'
Options issued for services transaction twenty	42,195	'	42,195	'	'	'	'	'
Net loss	-4,556,538	'	'	'	'	'	'	-4,556,538
Balance at Dec. 31, 2012	3,661,046	50,161	32,042,751	'	'	'	-15,827	-28,416,039
Balance, shares at Dec. 31, 2012	50,160,758	50,160,758	'	'	'	'	'	'
Balance at Dec. 31, 2006	574,772	27,889	5,966,430	'	'	-26,000	-15,827	-5,377,720
Balance, shares at Dec. 31, 2006	'	27,888,750	'	'	'	'	'	'
Common stock issued for future services transaction one	106,250	152	106,098	'	'	'	'	'
Common stock issued for future services transaction one, shares	'	151,785	'	'	'	'	'	'
Common stock issued for future services transaction two	580,000	1,000	579,000	'	'	'	'	'
Common stock issued for future services transaction two, shares	'	1,000,000	'	'	'	'	'	'
Common stock issued in private placement transaction one	1,241,000	2,482	1,238,518	'	'	'	'	'
Common stock issued in private placement transaction one, shares	'	2,482,000	'	'	'	'	'	'
Common stock issued in private placement transaction two	1,060,524	1,768	1,058,756	'	'	'	'	'
Common stock issued in private placement transaction two, shares	'	1,767,540	'	'	'	'	'	'
Common stock issued for services and settlement for accounts payable transaction one	35,000	100	34,900	'	'	'	'	'
Common stock issued for services and settlement for accounts payable transaction one, shares	'	100,000	'	'	'	'	'	'
Common stock issued for services transaction one	102,000	150	101,850	'	'	'	'	'
Common stock issued for services transaction one, shares	'	150,000	'	'	'	'	'	'
Common stock issued for services transaction two	135,000	150	134,850	'	'	'	'	'
Common stock issued for services transaction two, shares	'	150,000	'	'	'	'	'	'
Common stock issued for services transaction three	288,000	400	287,600	'	'	'	'	'
Common stock issued for services transaction three, shares	'	400,000	'	'	'	'	'	'
Common stock subscription rescinded during the period	-200,000	-400	-199,600	'	'	'	'	'
Common stock subscription rescinded during the period, shares	'	-400,000	'	'	'	'	'	'
Warrants issued for services transaction one	36,370	'	36,370	'	'	'	'	'
Warrants issued for services transaction two	52,180	'	52,180	'	'	'	'	'
Warrants issued for services transaction three	293,476	'	293,476	'	'	'	'	'
Warrants issued for services transaction four	140,490	'	140,490	'	'	'	'	'
Warrants issued for services transaction five	52,946	'	52,946	'	'	'	'	'
Warrants issued for services transaction six	61,449	'	61,449	'	'	'	'	'
Warrants issued for services transaction seven	52,292	'	52,292	'	'	'	'	'
Warrants issued for services transaction eight	1,159	'	1,159	'	'	'	'	'
Warrants issued for future services	348,000	'	348,000	'	'	'	'	'
Options issued for services transaction one	17,589	'	17,589	'	'	'	'	'
Options issued for services transaction two	43,757	'	43,757	'	'	'	'	'
Options issued for services transaction three	41,653	'	41,653	'	'	'	'	'
Deferred charges for common stock issued for future services	-928,000	'	'	'	-928,000	'	'	'
Amortization of deferred charges	773,333	'	'	'	773,333	'	'	'
Unrealized gain (loss) on securities	-32,610	'	'	'	'	-32,610	'	'
Net loss	-4,223,449	'	'	'	'	'	'	-4,223,449
Balance at Dec. 31, 2007	653,180	33,690	10,449,763	'	-154,667	-58,610	-15,827	-9,601,169
Balance, shares at Dec. 31, 2007	'	33,690,075	'	'	'	'	'	'
Common stock issued in private placement transaction one	414,000	690	413,310	'	'	'	'	'
Common stock issued in private placement transaction one, shares	'	690,001	'	'	'	'	'	'
Common stock issued for services transaction one	75,000	100	74,900	'	'	'	'	'
Common stock issued for services transaction one, shares	'	100,000	'	'	'	'	'	'
Common stock issued for services transaction two	360,000	200	359,800	'	'	'	'	'
Common stock issued for services transaction two, shares	'	200,000	'	'	'	'	'	'
Receivable for the issuance of common stock	-12,500	'	'	-12,500	'	'	'	'
Warrants issued for services transaction one	27,014	'	27,014	'	'	'	'	'
Warrants issued for services transaction two	10,885	'	10,885	'	'	'	'	'
Warrants issued for services transaction three	121,713	'	121,713	'	'	'	'	'
Warrants issued for services transaction four	48,738	'	48,738	'	'	'	'	'
Warrants issued for services transaction five	31,444	'	31,444	'	'	'	'	'
Warrants issued for services transaction six	12,487	'	12,487	'	'	'	'	'
Warrants issued for services transaction seven	976,193	'	976,193	'	'	'	'	'
Warrants issued for future services	'	'	332,000	'	-332,000	'	'	'
Exercise of warrants transaction one	80,000	320	79,680	'	'	'	'	'
Exercise of warrants transaction one, shares	'	320,000	'	'	'	'	'	'
Exercise of warrants transaction two	160,270	641	159,629	'	'	'	'	'
Exercise of warrants transaction two, shares	'	641,080	'	'	'	'	'	'
Exercise of warrants transaction three	135,000	270	134,730	'	'	'	'	'
Exercise of warrants transaction three, shares	'	270,000	'	'	'	'	'	'
Options issued for services transaction one	286,803	'	286,803	'	'	'	'	'
Options issued for services transaction two	30,750	'	30,750	'	'	'	'	'
Options issued for services transaction three	114,519	'	114,519	'	'	'	'	'
Options issued for services transaction four	525,263	'	525,263	'	'	'	'	'
Options issued for services transaction five	6,439	'	6,439	'	'	'	'	'
Amortization of deferred charges	431,337	'	'	'	431,337	'	'	'
Realized loss reclassification	58,610	'	'	'	'	58,610	'	'
Net loss	-4,340,607	'	'	'	'	'	'	-4,340,607
Balance at Dec. 31, 2008	206,538	35,911	14,196,060	-12,500	-55,330	'	-15,827	-13,941,776
Balance, shares at Dec. 31, 2008	'	35,911,156	'	'	'	'	'	'
Rights to purchase shares issued	132,058	'	132,058	'	'	'	'	'
Common stock issued in private placement transaction one	855,000	2,480	852,520	'	'	'	'	'
Common stock issued in private placement transaction one, shares	'	2,479,500	'	'	'	'	'	'
Common stock issued for services and settlement for accounts payable transaction one	25,000	100	24,900	'	'	'	'	'
Common stock issued for services and settlement for accounts payable transaction one, shares	'	100,000	'	'	'	'	'	'
Common stock issued for services and settlement for accounts payable transaction two	50,000	145	49,855	'	'	'	'	'
Common stock issued for services and settlement for accounts payable transaction two, shares	'	145,000	'	'	'	'	'	'
Common stock issued for services transaction one	58,000	100	57,900	'	'	'	'	'
Common stock issued for services transaction one, shares	'	100,000	'	'	'	'	'	'
Common stock issued for services transaction two	40,000	116	39,884	'	'	'	'	'
Common stock issued for services transaction two, shares	'	116,000	'	'	'	'	'	'
Common stock issued for services transaction three	75,000	100	74,900	'	'	'	'	'
Common stock issued for services transaction three, shares	'	100,000	'	'	'	'	'	'
Warrants issued for services transaction one	177,881	'	177,881	'	'	'	'	'
Exercise of purchase right agreement	45,138	181	44,957	'	'	'	'	'
Exercise of purchase right agreement, shares	'	180,550	'	'	'	'	'	'
Exercise of warrants transaction one	319,834	1,279	318,555	'	'	'	'	'
Exercise of warrants transaction one, shares	'	1,279,336	'	'	'	'	'	'
Exercise of warrants transaction two	400	400	'	'	'	'	'	'
Exercise of warrants transaction two, shares	'	400,000	'	'	'	'	'	'
Exercise of warrants transaction three	355,000	355	354,645	'	'	'	'	'
Exercise of warrants transaction three, shares	'	355,000	'	'	'	'	'	'
Options issued for services transaction one	199,234	'	199,234	'	'	'	'	'
Options issued for services transaction two	13,583	'	13,583	'	'	'	'	'
Options issued for services transaction three	67,838	'	67,838	'	'	'	'	'
Options issued for services transaction four	623,246	'	623,246	'	'	'	'	'
Options issued for services transaction five	61,346	'	61,346	'	'	'	'	'
Options issued for services transaction six	13,136	'	13,136	'	'	'	'	'
Options issued for services transaction seven	9,583	'	9,583	'	'	'	'	'
Options issued for services transaction eight	21,085	'	21,085	'	'	'	'	'
Contribution of accrued payroll	52,129	'	52,129	'	'	'	'	'
Amortization of deferred charges	55,330	'	'	'	55,330	'	'	'
Payment for the issuance of common stock	12,500	'	'	12,500	'	'	'	'
Net loss	-2,721,871	'	'	'	'	'	'	-2,721,871
Balance at Dec. 31, 2009	746,988	41,167	17,385,295	'	'	'	-15,827	-16,663,647
Balance, shares at Dec. 31, 2009	'	41,166,542	'	'	'	'	'	'
Balance at Dec. 31, 2012	3,661,046	50,161	32,042,751	'	'	'	-15,827	-28,416,039
Balance, shares at Dec. 31, 2012	50,160,758	50,160,758	'	'	'	'	'	'
Common stock issued for commitment shares	170,000	200	169,800	'	'	'	'	'
Common stock issued for commitment shares, shares	'	200,000	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction one	3,349	3	3,346	'	'	'	'	'
Common stock issued for additional commitment shares transaction one, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction two	3,228	3	3,225	'	'	'	'	'
Common stock issued for additional commitment shares transaction two, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction three	4,103	3	4,100	'	'	'	'	'
Common stock issued for additional commitment shares transaction three, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction four	4,073	3	4,070	'	'	'	'	'
Common stock issued for additional commitment shares transaction four, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction five	4,797	3	4,794	'	'	'	'	'
Common stock issued for additional commitment shares transaction five, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction six	4,677	3	4,674	'	'	'	'	'
Common stock issued for additional commitment shares transaction six, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction seven	3,590	3	3,587	'	'	'	'	'
Common stock issued for additional commitment shares transaction seven, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction eight	3,259	3	3,256	'	'	'	'	'
Common stock issued for additional commitment shares transaction eight, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction nine	3,198	3	3,195	'	'	'	'	'
Common stock issued for additional commitment shares transaction nine, shares	'	3,017	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction ten	1,782	2	1,780	'	'	'	'	'
Common stock issued for additional commitment shares transaction ten, shares	'	1,730	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction eleven	1,452	1	1,451	'	'	'	'	'
Common stock issued for additional commitment shares transaction eleven, shares	'	1,370	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction twelve	1,587	2	1,585	'	'	'	'	'
Common stock issued for additional commitment shares transaction twelve, shares	'	1,526	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction thirteen	1,553	1	1,552	'	'	'	'	'
Common stock issued for additional commitment shares transaction thirteen, shares	'	1,508	'	'	'	'	'	'
Common stock issued for additional commitment shares transaction fourteen	1,508	2	1,506	'	'	'	'	'
Common stock issued for additional commitment shares transaction fourteen, shares	'	1,508	'	'	'	'	'	'
Common stock issued to institutional investor transaction one	200,000	187	199,813	'	'	'	'	'
Common stock issued to institutional investor transaction one, shares	'	186,916	'	'	'	'	'	'
Common stock issued to institutional investor transaction two	199,999	196	199,803	'	'	'	'	'
Common stock issued to institutional investor transaction two, shares	'	196,078	'	'	'	'	'	'
Common stock issued to institutional investor transaction three	200,000	193	199,807	'	'	'	'	'
Common stock issued to institutional investor transaction three, shares	'	192,864	'	'	'	'	'	'
Common stock issued to institutional investor transaction four	200,000	176	199,824	'	'	'	'	'
Common stock issued to institutional investor transaction four, shares	'	175,948	'	'	'	'	'	'
Common stock issued to institutional investor transaction five	200,001	160	199,841	'	'	'	'	'
Common stock issued to institutional investor transaction five, shares	'	159,579	'	'	'	'	'	'
Common stock issued to institutional investor transaction six	200,000	149	199,851	'	'	'	'	'
Common stock issued to institutional investor transaction six, shares	'	149,254	'	'	'	'	'	'
Common stock issued to institutional investor transaction seven	200,000	175	199,825	'	'	'	'	'
Common stock issued to institutional investor transaction seven, shares	'	175,439	'	'	'	'	'	'
Common stock issued to institutional investor transaction eight	200,000	192	199,808	'	'	'	'	'
Common stock issued to institutional investor transaction eight, shares	'	192,308	'	'	'	'	'	'
Common stock issued to institutional investor transaction nine	200,000	200	199,800	'	'	'	'	'
Common stock issued to institutional investor transaction nine, shares	'	200,000	'	'	'	'	'	'
Common stock issued to institutional investor transaction ten	86,500	100	86,400	'	'	'	'	'
Common stock issued to institutional investor transaction ten, shares	'	100,000	'	'	'	'	'	'
Common stock issued to institutional investor transaction eleven	90,830	100	90,730	'	'	'	'	'
Common stock issued to institutional investor transaction eleven, shares	'	100,000	'	'	'	'	'	'
Common stock issued to institutional investor transaction twelve	101,170	100	101,070	'	'	'	'	'
Common stock issued to institutional investor transaction twelve, shares	'	100,000	'	'	'	'	'	'
Common stock issued to institutional investor transaction thirteen	100,000	100	99,900	'	'	'	'	'
Common stock issued to institutional investor transaction thirteen, shares	'	100,000	'	'	'	'	'	'
Common stock issued to institutional investor transaction fourteen	100,000	100	99,900	'	'	'	'	'
Common stock issued to institutional investor transaction fourteen, shares	'	100,000	'	'	'	'	'	'
Warrants issued for services transaction one	41,738	'	41,738	'	'	'	'	'
Warrants issued for services transaction two	69,455	'	69,455	'	'	'	'	'
Warrants issued for services transaction three	24,658	'	24,658	'	'	'	'	'
Exercise of warrants transaction one	15,625	13	15,612	'	'	'	'	'
Exercise of warrants transaction one, shares	'	12,500	'	'	'	'	'	'
Exercise of warrants transaction two	6,900	20	6,880	'	'	'	'	'
Exercise of warrants transaction two, shares	'	20,000	'	'	'	'	'	'
Exercise of options	38,733	38	38,695	'	'	'	'	'
Exercised	'	38,350	'	'	'	'	'	'
Exercise of options two	11,250	25	11,225	'	'	'	'	'
Exercised two	'	25,000	'	'	'	'	'	'
Reversal of common stock issuance	'	-2	2	'	'	'	'	'
Reversal of common stock issuance, shares	'	2,000	'	'	'	'	'	'
Options issued for services transaction one	80,634	'	80,634	'	'	'	'	'
Options issued for services transaction two	48,378	'	48,378	'	'	'	'	'
Options issued for services transaction three	13,531	'	13,531	'	'	'	'	'
Options issued for services transaction four	26,232	'	26,232	'	'	'	'	'
Options issued for services transaction five	51,252	'	51,252	'	'	'	'	'
Options issued for services transaction six	29,154	'	29,154	'	'	'	'	'
Options issued for services transaction seven	151,350	'	151,350	'	'	'	'	'
Options issued for services transaction eight	36,287	'	36,287	'	'	'	'	'
Options issued for services transaction nine	37,242	'	37,242	'	'	'	'	'
Options issued for services transaction ten	6,920	'	6,920	'	'	'	'	'
Options issued for services transaction eleven	33,986	'	33,986	'	'	'	'	'
Options issued for services transaction twelve	2,394	'	2,394	'	'	'	'	'
Options issued for services transaction thirteen	60,399	'	60,399	'	'	'	'	'
Options issued for services transaction fourteen	46,337	'	46,337	'	'	'	'	'
Options issued for services transaction fifteen	50,801	'	50,801	'	'	'	'	'
Net loss	($3,912,326)	'	'	'	'	'	'	($3,912,326)
Balance at Dec. 31, 2013	'	'	'	'	'	'	'	'

STATEMENT_OF_STOCKHOLDERS_EQUI1

STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) (USD $)

Dec. 30, 2013

Jun. 30, 2013

Dec. 31, 2012

Dec. 31, 2010

31-May-05

Dec. 31, 2004

Jul. 31, 2009

Aug. 31, 2008

Mar. 31, 2008

Mar. 31, 2007

Feb. 28, 2007

Nov. 30, 2006

Jun. 30, 2006

31-May-06

Feb. 28, 2006

Aug. 31, 2005

Aug. 31, 2004

Jul. 31, 2004

Aug. 31, 2005

Jun. 30, 2009

Jan. 31, 2009

Apr. 30, 2007

Sep. 30, 2011

Jun. 30, 2011

Mar. 31, 2011

Dec. 31, 2010

Nov. 30, 2010

Aug. 31, 2010

Jun. 30, 2009

Jan. 31, 2009

Nov. 30, 2007

Oct. 31, 2007

Jan. 31, 2012

Aug. 31, 2011

Jan. 31, 2012

Aug. 31, 2011

Oct. 31, 2007

Dec. 31, 2010

Jun. 30, 2009

Apr. 30, 2005

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2008

Dec. 31, 2007

Dec. 31, 2006

Dec. 31, 2007

Dec. 31, 2013

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Jul. 31, 2013

Dec. 31, 2012

31-May-12

Mar. 31, 2012

Dec. 31, 2011

Apr. 30, 2011

Jan. 31, 2011

Mar. 31, 2010

Jan. 31, 2010

Jun. 30, 2009

31-May-08

Dec. 31, 2007

Oct. 31, 2007

31-May-07

Apr. 30, 2007

Mar. 31, 2007

Oct. 31, 2005

Sep. 30, 2005

31-May-05

Oct. 31, 2007

Apr. 30, 2007

Mar. 31, 2008

Apr. 30, 2007

Jun. 30, 2006

Dec. 31, 2005

Jun. 30, 2013

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2005

Jun. 30, 2013

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2010

Jan. 31, 2009

Aug. 31, 2013

31-May-13

Mar. 31, 2013

Nov. 30, 2012

Aug. 31, 2012

Jun. 30, 2012

31-May-12

Mar. 31, 2012

Dec. 31, 2011

Nov. 30, 2011

Aug. 31, 2011

31-May-11

Dec. 31, 2010

Aug. 31, 2010

Jun. 30, 2009

Feb. 28, 2009

Jan. 31, 2009

Nov. 30, 2008

Aug. 31, 2008

Jul. 31, 2008

Jan. 31, 2008

Nov. 30, 2007

Feb. 28, 2006

31-May-13

Nov. 30, 2012

Aug. 31, 2012

Feb. 28, 2006

Nov. 30, 2012

Common Stock Issued For Future Services Transaction One [Member]

Common Stock Issued For Future Services Transaction Two [Member]

Common Stock Issued For Services And Settlement For Accounts Payable [Member]

Common Stock Issued For Services Transaction One [Member]

Common Stock Issued For Services Transaction Two [Member]

Common Stock Issued In Private Placement Transaction One [Member]

Common Stock Issued In Private Placement Transaction Two [Member]

Common Stock Subscription Rescinded During Period [Member]

Common Stock Issued For Commitment Shares [Member]

Common Stock Issued For Additional Commitment Shares Transaction One [Member]

Common Stock Issued For Additional Commitment Shares Transaction Two [Member]

Common Stock Issued For Additional Commitment Shares Transaction Three [Member]

Common Stock Issued For Additional Commitment Shares Transaction Four [Member]

Common Stock Issued For Additional Commitment Shares Transaction Five [Member]

Common Stock Issued For Additional Commitment Shares Transaction Six [Member]

Common Stock Issued For Additional Commitment Shares Transaction Seven [Member]

Common Stock Issued For Additional Commitment Shares Transaction Eight [Member]

Common Stock Issued For Additional Commitment Shares Transaction Nine [Member]

Common Stock Issued For Additional Commitment Shares Transaction Ten [Member]

Common Stock Issued For Additional Commitment Shares Transaction Eleven [Member]

Common Stock Issued For Additional Commitment Shares Transaction Twelve [Member]

Common Stock Issued For Additional Commitment Shares Transaction Thirteen [Member]

Common Stock Issued For Additional Commitment Shares Transaction Fourteen [Member]

Common Stock Issued For Additional Commitment Shares Transaction Fifteen [Member]

Common Stock Issued For Additional Commitment Shares Transaction Sixteen [Member]

Common Stock Issued For Additional Commitment Shares Transaction Seventeen [Member]

Common Stock Issued For Additional Commitment Shares Transaction Eighteen [Member]

Common Stock Issued For Additional Commitment Shares Transaction Nineteen [Member]

Common Stock Issued For Additional Commitment Shares Transaction Twenty [Member]

Common Stock Issued For Additional Commitment Shares Transaction Twenty-One [Member]

Common Stock Issued For Additional Commitment Shares Transaction Twenty-Two [Member]

Common Stock Issued To Institutional Investor Transaction One [Member]

Common Stock Issued To Institutional Investor Transaction Two [Member]

Common Stock Issued To Institutional Investor Transaction Three [Member]

Common Stock Issued To Institutional Investor Transaction Four [Member]

Common Stock Issued To Institutional Investor Transaction Five [Member]

Common Stock Issued To Institutional Investor Transaction Six [Member]

Common Stock Issued To Institutional Investor Transaction Seven [Member]

Common Stock Issued To Institutional Investor Transaction Eight [Member]

Common Stock Issued To Institutional Investor Transaction Nine [Member]

Common Stock Issued To Institutional Investor Transaction Ten [Member]

Common Stock Issued To Institutional Investor Transaction Eleven [Member]

Common Stock Issued To Institutional Investor Transaction Twelve [Member]

Common Stock Issued To Institutional Investor Transaction Thirteen [Member]

Common Stock Issued To Institutional Investor Transaction Fourteen [Member]

Common Stock Issued To Institutional Investor Transaction Fifteen [Member]

Common Stock Issued To Institutional Investor Transaction Sixteen [Member]

Common Stock Issued To Institutional Investor Transaction Seventeen [Member]

Common Stock Issued To Institutional Investor Transaction Eighteen [Member]

Common Stock Issued To Institutional Investor Transaction Nineteen [Member]

Common Stock Issued To Institutional Investor Transaction Twenty [Member]

Common Stock Issued To Institutional Investor Transaction Twenty-One [Member]

Reversal Of Common Stock Issuance [Member]

Warrants Issued For Services Transaction One [Member]

Warrants Issued For Services Transaction Two [Member]

Warrants Issued For Future Services [Member]

Exercise Of Warrants Transaction One [Member]

Exercise Of Warrants Transaction Two [Member]

Exercise Of Warrants Transaction Three [Member]

Exercise Of Warrants Transaction Four [Member]

Rights To Purchase Shares Issued [Member]

Exercise Of Purchase Right Agreement [Member]

Options Issued For Services Transaction One [Member]

Options Issued For Services Transaction Two [Member]

Options Issued For Services Transaction Three [Member]

Options Issued For Services Transaction Four [Member]

Options Issued For Services Transaction Five [Member]

Options Issued For Services Transaction Six [Member]

Options Issued For Services Transaction Seven [Member]

Minimum [Member]

Maximum [Member]

Equity Issuance [Line Items]

Equity issuance, amount per share

$0.75

$1.80

$0.75

$0.58

$0.70

$0.49

$1.45

$1.55

$0.90

$2.79

$0.12

$0.16

$2.92

$0.34

$0.25

$0.35

$1.45

$1.04

$1.45

$1.20

$0.93

$1.25

$0.34

$0.58

$0.72

$0.68

$0.65

$0.90

$1.25

$0.90

$0.34

$0.25

$0.60

$0.50

$0.60

$0.50

$0.85

$1.08

$1.11

$1.64

$1.15

$1.07

$1.67

$1.36

$2.87

$1.35

$1.97

$2.59

$2.60

$1.55

$2.64

$1.19

$2.23

$1.08

$1.80

$1.06

$1.88

$1.06

$1.92

$1.04

$1.60

$1.03

$1.93

$1.70

$1.35

$1.28

$1.18

$1.08

$1.09

$1.04

$1.10

$1.07

$1.01

$1.08

$1.03

$1.20

$1.04

$1.58

$1.14

$1.66

$1.25

$1.90

$1.34

$2.07

$1.14

$2.19

$1.04

$1.68

$1.81

$0.87

$1.53

$0.91

$1.67

$1.01

$1.51

$1.68

$1.13

$1.11

$1.10

$1.06

$1.02

$0.50

$0.49

$0.78

$0.97

$1.69

$1.05

$0.98

$1.05

$1.86

$1.83

$0.85

$1.63

$0.55

$0.61

$0.56

$0.69

$0.63

$0.53

$1.45

$1.13

$0.78

$0.63

$0.83

$1.55

$1.45

$0.33

$0.25

$0.71

$0.96

$1.08

$0.27

$0.74

$0.73

$1.23

$1.37

$0.82

$0.53

$0.82

$0.97

$1.14

$1.31

$0.85

$0.38

$0.53

$0.50

$1.36

$1.48

$0.60

$1.01

$0.81

$0.25

$0.75

$1.09

$0.24

$0.29

$0.26

$0.30

$0.28

Conversion of notes payable, price per share

$0.16

Exercise of warrants, price per share

1.25

0.25

0.345

0.25

0.345

0.001

0.5

0.25

0.5

Exercise of options, price per share

$0.45

$1.01

$0.65

$0.25

STATEMENTS_OF_CASH_FLOW

STATEMENTS OF CASH FLOW (USD $)	12 Months Ended		120 Months Ended
STATEMENTS OF CASH FLOW (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
Net loss	($3,912,326)	($4,556,538)	($32,328,365)
Adjustment to reconcile net loss to net cash used in operating activities	'	'	'
Amortization of deferred charges	'	'	4,392,456
Amortization of prepaid expenses	'	'	75,000
Warrants issued for services	135,851	291,326	4,194,624
Stock options issued for services	674,897	1,816,430	7,464,705
Common stock issued for services and fees	212,156	132,420	1,668,447
Purchase right agreement amortization	'	'	132,058
Depreciation and amortization of patents	126,773	79,217	349,417
Realized gain on investments	'	'	-3,911
Realized gain on disposal of assets	'	'	-637
(Increase) decrease in assets	'	'	'
Receivables	'	'	-30,461
Prepaid expenses and other current assets	-42,229	-48,219	-132,204
Increase (decrease) in liabilities	'	'	'
Accounts payable	-30,974	-43,449	198,325
Accounts payable and accrued expenses- related parties	-6,789	-14,610	-42,109
Accrued expenses	4,611	-25,039	85,489
Net cash used in operating activities	-2,838,030	-2,368,462	-13,977,166
CASH FLOWS FROM INVESTING ACTIVITIES	'	'	'
Cost of intangibles	-69,875	-83,248	-592,910
Proceeds from sale of available for sale securities	'	'	203,911
Proceeds from receipt of note receivable	'	'	100,000
Purchase of available for sale securities	'	'	-200,000
Purchase of equipment, furniture and leasehold improvements	-109,278	-265,634	-561,157
Net cash used in investing activities	-179,153	-348,882	-1,050,156
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Issuance of common stock, private placement	'	'	7,495,524
Common stock rescinded, private placement	'	'	-200,000
Issuance of common stock, exercise of options and warrants	72,508	444,400	2,093,912
Issuance of common stock, exercise of purchase right agreement	'	'	45,138
Issuance of common stock, institutional investor	2,278,500	4,849,999	7,328,499
Repayment of notes payable	'	'	-14,970
Proceeds from subscription receivable	'	'	19,000
Advances to stockholders	'	'	-4,933
Proceeds from convertible notes	'	'	529,000
Advances from officers	'	'	1,498
Net cash provided by financing activities	2,351,008	5,294,399	17,292,668
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	-666,175	2,577,055	2,265,346
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	2,936,879	359,824	5,328
CASH AND CASH EQUIVALENTS - END OF PERIOD	'	2,936,879	'
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION	'	'	'
CASH PAID DURING THE PERIOD FOR: Interest	'	109	23,341
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES	'	'	'
Common stock issued in exchange for deferred charges	'	'	3,142,400
Warrants issued in exchange for deferred charges	'	'	1,581,056
Common stock issued as settlement for accounts payable	'	'	74,708
Accrued interest contributed as capital	'	'	35,624
Common stock issued in the conversion of notes payable	'	'	529,000
Acquisition of automobile through loan payable	'	'	24,643
Common stock issued upon exercise of a warrant in exchange for receivable	'	'	75,000
Insurance company pay off of note payable	'	'	9,673
Receivable for issuance of common stock	'	'	210,001
Contribution of officer accrued payroll	'	'	52,129
Common stock issued for prepaid expense	'	'	$75,000

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	History and Nature of Business
	Lightwave Logic, Inc., formerly Third-Order Nanotechnologies, Inc., formerly PSI-Tec Holdings, Inc., formerly Eastern Idaho Internet Service, Inc. (the "Company") was organized under the laws of the State of Nevada in 1997. The Company was engaged in the business of marketing internet services until June 30, 1998, at which time the principal assets of the business were sold and operations were discontinued. The Company was inactive until the acquisition of PSI-TEC Corporation ("PSI-TEC") on July 14, 2004, at which time the name was changed to PSI-TEC Holdings, Inc.

	Development Stage
	PSI-TEC was incorporated in 1995 under the laws of the State of Delaware. PSI-TEC primarily conducted research for the United States Government under a contract, which expired in 2003. Beginning January 1, 2004, PSI-TEC was engaged in the development of electro-optic polymers for application in the electro-optic device markets. PSI-TEC is considered a development stage company as defined in Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 "Development Stage Entities" from the inception of the development stage on January 1, 2004.

	Merger
	On July 14, 2004, the Company acquired PSI-TEC. Under the terms of the merger agreement, the stockholders of PSI-TEC received 15,600,000 shares of common stock in exchange for its 2,206,280 shares. Following the merger, the Company changed its name to PSI-TEC Holdings, Inc. Under accounting principles generally accepted in the United States, the share exchange is considered to be a capital transaction in substance rather than a business combination. That is, the share exchange is equivalent to the issuance of stock by PSI-TEC Holdings, Inc. for the net monetary assets of PSI-TEC, accompanied by a recapitalization, and is accounted for as a change of capital structure. Accordingly, the accounting for the share exchange was identical to that resulting from a reverse acquisition, except no goodwill was recorded. Under reverse takeover accounting, the post-reverse acquisition comparative historical financial statements of the legal acquirer, PSI-TEC Holdings, Inc., are those of the legal acquiree, PSI-TEC, which is considered to be the accounting acquirer. On October 20, 2006, PSI-TEC Holdings, Inc. and PSI-TEC merged and changed its name to Third-Order Nanotechnologies, Inc. On March 10, 2008, Third-Order Nanotechnologies, Inc. changed its name to Lightwave Logic, Inc.


	Basis of Presentation
	The financial statements are presented in accordance with Financial Accounting Standards Board of Accounting Standards Codification ("FASB ASC") 915 for development stage companies. The accompanying financial statements are presented in accordance with accounting principles generally accepted in the United States of America.

	Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management's best knowledge of current events and actions the Company may undertake in the future, actual results could differ from the estimates.

	Cash Equivalents
	For the purposes of the statement of cash flows, the Company considers all highly liquid instruments with maturities of three months or less at the time of purchase to be cash equivalents.

	Concentration of Credit Risk
	Certain financial instruments potentially subject the Company to concentrations of credit risk. These financial instruments consist primarily of cash. At December 31, 2013, the Company did have deposits with a financial institution that exceed the Federal Depository Insurance coverage.

	Property and Equipment
	Equipment is stated at cost. Depreciation is principally provided by use of straight-line methods for financial and tax reporting purposes over the estimated useful lives of the assets, generally 5 years. When property is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in operations.

	Intangible Assets
	Definite-lived intangible assets are stated at cost. Patents are amortized over their estimated useful lives, generally 20 years. When certain patent applications are abandoned by the Company for claims that are covered by patents already granted to the Company, the cost of patent applications and accumulated amortization are removed from the accounts and the resulting expense is reflected in the Statement of Operations.

	Fair Value of Financial Instruments
	The Company's financial instruments consist of cash, accounts payable and accrued expenses. The carrying values of cash, accounts payable and accrued expenses approximate fair value because of their short maturities.

	Income Taxes
	The Company follows FASB ASC 740, "Income Taxes," which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.

	Loss Per Share
	The Company follows FASB ASC 260, "Earnings per Share", resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss in 2013 and 2012, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.

	Recoverability of Long Lived Assets
	The Company follows FASB ASC 360, "Property, Plant, and Equipment". Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the related carrying amount may not be recoverable. When required, impairment losses on assets to be held and used are recognized based on the excess of the asset's carrying amount.

	Comprehensive Income
	The Company follows FASB ASC 220.10, "Reporting Comprehensive Income." Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since the Company has no items of other comprehensive income, comprehensive income (loss) is equal to net loss.

	Recently Adopted Accounting Pronouncements
	As of December 31, 2013 and for the year then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company's financial statements.

	Recently Issued Accounting Pronouncements Not Yet Adopted
	As of December 31, 2013, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.

MANAGEMENTS_PLANS

MANAGEMENT'S PLANS	12 Months Ended
MANAGEMENT'S PLANS	Dec. 31, 2013
MANAGEMENT'S PLANS [Abstract]	'
MANAGEMENT'S PLANS	'
	NOTE 2 - MANAGEMENT'S PLANS

	The Company currently has a cash position of approximately $2,000,000. Based upon the current cash position and expenditures of approximately $270,000 per month and no debt service, management believes the Company has sufficient funds currently to finance its operations through September 2014. In June 2013, the Company signed an agreement with an institutional investor to sell up to $20 million of common stock. Under the agreement subject to certain conditions and at the Company's sole discretion, the institutional investor has committed to invest up to $20 million in the Company's common stock over a 30-month period with the remaining available amount of $19,343,840. The Company filed a registration statement with the U.S. Securities and Exchange Commission covering the resale of the shares that may be issued to the institutional investor. The institutional investor is obligated to make purchases as the Company directs in accordance with the agreement that may be terminated by the Company at any time, without cost or penalty. Sales of shares will be made in specified amounts and at prices that are based upon the market prices of the Company's common stock. Additional funding may also be provided by the exercise of 1,441,000 outstanding options and warrants expiring during 2014 at an exercise price of $0.34 and $0.72, which may raise additional capital up to approximately $873,000. With additional capital raised, the Company expects to achieve a level of revenues attractive enough to fulfill its development activities and achieve a level of revenue adequate to support the Company's business model. Also, historically the Company has successfully raised sufficient cash to fund its operations. The Company continues to develop and test its next generation Electro-Optic and third-order material platform to support and cultivate potential customers, strategic partners and develop photonic devices. Management believes the Company's initial revenue stream will be in prototype devices, application and non-recurring engineering charges, and material charges for specialty non-linear application prior to moving into full commercialization and production.

PROPERTY_AND_EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
PROPERTY AND EQUIPMENT	Dec. 31, 2013
PROPERTY AND EQUIPMENT [Abstract]	'
PROPERTY AND EQUIPMENT	'
	NOTE 3 - PROPERTY AND EQUIPMENT

	Equipment consists of the following:

		December 31,		December 31,
		2013		2012

	Office equipment	$	24,244	$	12,741
	Lab equipment		474,049		388,521
	Furniture		4,061		4,061
	Leasehold improvements		37,519		28,134
			539,873		433,457
	Less: Accumulated depreciation		241,513		132,463

		$	298,360	$	300,994

	Depreciation expense for the years ending December 31, 2013 and 2012 was $111,912 and $53,391.

INTANGIBLE_ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2013
INTANGIBLE ASSETS [Abstract]	'
INTANGIBLE ASSETS	'
	NOTE 4 - INTANGIBLE ASSETS

	This represents legal fees and patent fees associated with the prosecution of patent applications. The Company has recorded amortization expenses on the Spacer and Chromophore patents granted by the United States Patent and Trademark Office in February 2011, April 2011 and September 2012, which are amortized over its legal life of 20 years and Chromophore patent granted by the Australian Patent Office in November 2012 which is amortized over their legal life of 20 years. Certain patent applications are abandoned by the Company when the claims are covered by patents already granted to the Company. Patent applications abandoned have been written off at full capitalized cost. No amortization expense has been recorded on the remaining patent applications since patents have yet to be granted. Once the patents are granted, the cost of the patents will be amortized over their legal lives, which is generally 20 years.

	Patents consists of the following:

		December 31,		December 31,
		2013		2012

	Patents	$	579,235	$	509,360
	Less: Accumulated amortization		35,695		20,834

		$	543,540	$	488,526

	Amortization expense for the years ending December 31, 2013 and 2012 was $14,861 and $12,151. Expense for abandoned patents for claims covered by patents already granted to the Company are recorded in research and development expenses and for the years ending December 31, 2013 and 2012 were $0 and $13,675.

COMMITMENTS

COMMITMENTS	12 Months Ended
	Dec. 31, 2013
COMMITMENTS [Abstract]	'
COMMITMENTS	'
	NOTE 5 - COMMITMENTS

	The Company is obligated under an operating lease for office space expiring in 5 years. The commencement date will be in 2014 upon completion of tenant improvements. The aggregate minimum future lease payments under the operating leases are as follows:

	DECEMBER 31,	AMOUNT

	2014	$	28,025
	2015		46,038
	2016		47,407
	2017		48,817
	Thereafter		56,581
	TOTAL	$	226,868

	The Company is obligated under operating leases for laboratory space expiring April 2014.

	Aggregate minimum future lease payments under the operating leases are as follows:

	YEAR ENDING
	DECEMBER 31,	AMOUNT

	2014	$	22,708

	Rent expense approximating $68,125 and $53,563 is included in research and development expenses for the years ended December 31, 2013 and 2012.

INCOME_TAXES

INCOME TAXES	12 Months Ended
INCOME TAXES	Dec. 31, 2013
INCOME TAXES [Abstract]	'
INCOME TAXES	'
	NOTE 6 - INCOME TAXES

	As discussed in Note 1, the Company utilizes the asset and liability method of accounting for income taxes in accordance with FASB ASC 740.

	The income tax benefit (provision) consists of the following:

		2013			2012

	Current	$	(1,345,000	)	$	(1,563,000	)
	Deferred		(370,000	)		(576,000	)
	Change in valuation allowance		1,715,000			2,139,000


		$	-		$	-

	The reconciliation of the statutory federal rate to the Company's effective income tax rate is as follows:

		2013						2012

		Amount			%			Amount			%
	Income tax benefit at U.S.
	federal income tax rate	$	(1,330,000	)		(34	)	$	(1,549,000	)		(34	)
	State tax, net of federal tax effect		(352,000	)		(9	)		(410,000	)		(9	)
	Non-deductible share-based compensation		(33,000	)		(1	)		(180,000	)		(4	)
	Change in valuation allowance		1,715,000			44			2,139,000			47

		$	-			-		$	-			-

	The components of deferred tax assets as of December 31, 2013, and December 31, 2012 are as follows:

		2013			2012

	Deferred tax asset for NOL carryforwards	$	9,992,000		$	8,647,000
	Share-based compensation		3,335,000			2,966,000
	Accrued expenses		17,000			17,000
	Valuation allowance		(13,344,000	)		(11,630,000	)

		$	-		$	-

	The valuation allowance for deferred tax assets as of December 31, 2013 and 2012 was $13,344,000 and $11,630,000, respectively. The change in the total valuation for the years ended December 31, 2013 and 2012 was an increase of $1,715,000 and $2,139,000, respectively. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the net operating losses and temporary differences become deductible. Management considered projected future taxable income and tax planning strategies in making this assessment. The value of the deferred tax assets was offset by a valuation allowance, due to the current uncertainty of the future realization of the deferred tax assets.

	As of December 31, 2013, the Company had net operating loss carry forwards of approximately $23,200,000, expiring through the year ending December 31, 2033. This amount can be used to offset future taxable income of the Company.

	The timing and manner in which the Company can utilize operating loss carryforwards in any year may be limited by provisions of the Internal Revenue Code regarding changes in ownership of corporations. Such limitation may have an impact on the ultimate realization of its carryforwards and future tax deductions.

	On January 1, 2007, the Company adopted FASB ASC 740.10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise's financial statements. Recognition involves a determination of whether it is more likely than not that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information. The adoption of FASB ASC 740.10 did not require an adjustment to the Company's financial statements.

	The Company's policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of January 1, 2013, the Company had no unrecognized tax benefits and no charge during 2013, and accordingly, the Company did not recognize any interest or penalties during 2013 related to unrecognized tax benefits. There is no accrual for uncertain tax positions as of December 31, 2013.

	The Company files U.S. income tax returns and a state income tax return. With few exceptions, the U.S. and state income tax returns filed for the tax years ending on December 31, 2010 and thereafter are subject to examination by the relevant taxing authorities.

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
STOCKHOLDERS' EQUITY	Dec. 31, 2013
STOCKHOLDERS' EQUITY [Abstract]	'
STOCKHOLDERS' EQUITY	'
	NOTE 7 - STOCKHOLDERS' EQUITY

	Preferred Stock
	Pursuant to the Company's Articles of Incorporation, the Company's board of directors is empowered, without stockholder approval, to issue series of preferred stock with any designations, rights and preferences as they may from time to time determine. The rights and preferences of this preferred stock may be superior to the rights and preferences of the Company's common stock; consequently, preferred stock, if issued could have dividend, liquidation, conversion, voting or other rights that could adversely affect the voting power or other rights of the common stock. Additionally, preferred stock, if issued, could be utilized, under special circumstances, as a method of discouraging, delaying or preventing a change in control of the Company's business or a takeover from a third party.

	Common Stock and Warrants
	During March 2007, the Company issued 1,000,000 shares of common stock to a related party for management consulting services valued at $580,000, fair value. During April 2007, the Company issued 500,000 warrants as an addendum to the original contract for management consulting services valued at $348,000, fair value. This contract was recorded as a contra-equity deferred charges account and is amortized over one year, the term of the contract. Management consulting expense recognized during 2008 and 2007 is $154,667 and $773,333. This contract was renewed in March, 2008. In December 2010, the warrant was partially exercised to purchase 100,000 shares of common stock for proceeds of $25,000. In April 2012, the warrant was exercised to purchase the remaining 400,000 shares of common stock for proceeds of $100,000.

	During April 2007, the Company issued warrants to purchase 900,000 shares of common stock for consulting services at an exercise price of $0.25 per share. The warrants were valued at $604,416 using the Black-Scholes Option Pricing Formula and expensed over the life of the contracts associated with the consulting services, which is one year. The consulting expense recognized during 2008 and 2007 is $170,451 and $433,966. In July 2008, the warrant was partially exercised to purchase 20,000 shares of common stock for proceeds of $5,000. In April 2010, the warrant was partially exercised to purchase 380,000 shares of common stock for proceeds of $95,000. In April 2012, the warrant was exercised to purchase the remaining 500,000 shares of common stock for proceeds of $125,000.

	During April 2008, the Company issued a warrant to purchase 600,000 shares of common stock at a purchase price of $0.73 per share for consulting services rendered. The warrant was valued at $976,193, fair value, using the Black-Scholes Option Pricing Formula, vesting immediately. For the year ended December 31, 2008, the Company recognized $976,193 in consulting expense. During January 2013, the warrant agreement was amended from 600,000 warrants to 400,000 shares at an exercise price of $0.73 expiring October 2013 and 200,000 shares were rescinded. The modification did not result in the recognition of any additional expense. In October 2013, the warrant to purchase 400,000 shares of common stock expired.

	In November 2008, the Company issued an option to purchase 250,000 shares of common stock under the 2007 Stock Option Plan at a purchase price of $.65 per share to a new member of its board of directors. Using the Black-Scholes Option Pricing Formula, the options were valued at $125,911, fair value, vesting 62,500 immediately and the remaining in annual equal installments of 62,500 over the next three years. The expense is being recognized based on vesting terms over a three year period. The expense recognized during 2011, 2010, 2009 and 2008 is $26,648, $31,478, $61,346 and $6,439. In January 2012, the option was exercised to purchase 250,000 shares of common stock for proceeds of $162,500.

	In January 2009, an employee was granted with an option to purchase up to 25,000 shares of common stock at a purchase price of $.25 per share. Using the Black-Scholes Option Pricing Formula, the options were valued at $13,136, fair value. These options expire in 5 years and vest immediately. The expense recognized during 2009 is $13,136. In May 2010, the option was partially exercised to purchase 15,000 shares of common stock for proceeds of $3,750. As of December 31, 2013, options to purchase 10,000 shares of common stock are still outstanding. In January 2014, the remaining 10,000 options were exercised to purchase 10,000 shares of common stock for proceeds of $2,500.

	In February 2009, an employee was granted with an option to purchase up to 25,000 shares of common stock at a purchase price of $.45 per share. Using the Black-Scholes Option Pricing Formula, the options were valued at valued at $9,583, fair value. These options expire in 5 years and vest immediately. The expense recognized during 2009 is $9,583. During December 2013, the options were fully exercised for proceeds of $11,250.

	During June 2009, the Company issued a warrant to purchase 464,000 shares of common stock at a purchase price of $0.34 per share for accounting services rendered. The warrant was valued at $391,342 using the Black-Scholes Option Pricing Formula, vesting 46,400 immediately and the remaining on equal monthly installments of 23,200 over the next eighteen months. The warrant expires in 5 years. The expense is being recognized based on service terms of the agreement over a twenty two month period. The expense recognized during 2010 and 2009 is $213,459 and $177,883. In April 2010, the warrant was partially exercised to purchase 10,000 shares of common stock for proceeds of $3,450. In February 2012, the warrant was partially exercised to purchase 20,000 shares of common stock for proceeds of $6,900. In June 2013, the warrant was partially exercised to purchase 20,000 shares of common stock for proceeds of $6,900. As of December 31, 2013, warrants to purchase 414,000 shares of common stock are still outstanding. In March 2014, warrants were exercised to purchase 250,000 shares of common stock for proceeds of $86,250.

	During 2010, the Company issued 1,500,000 shares of common stock and warrants to purchase 375,000 shares of common stock with 156,250 warrants expiring September 2011 and 218,750 warrants expiring December 2011 for proceeds of $1,500,000 in accordance to a private placement memorandum as amended on September 14, 2010. Pursuant to the terms of the offerings, up to 30 units were offered at the purchase price of $50,000 per unit, with each unit comprised of 50,000 shares and a warrant to purchase 12,500 shares of common stock at $1.25 per share. During September 2011, all warrants were extended one year expiring September 2012 and December 2012. In January 2012, some warrants were exercised to purchase 40,000 shares of common stock for proceeds of $50,000. During August 2012, all remaining warrants were extended six months expiring March 2013 and June 2013. During March 2013, 335,000 warrants were extended three months expiring June 2013 and September 2013. The extension did not result in the recognition of any additional expense. In March 2013, a warrant was exercised to purchase 12,500 shares of common stock for proceeds of $15,625. In June 2013, warrants to purchase 143,750 shares of common stock expired. The remaining warrants to purchase 178,750 shares of common stock expired as of September 30, 2013.


	In May 2011, the Company has signed an agreement with an institutional investor to sell up to $20 million of common stock. Under the agreement subject to certain conditions and at the Company's sole discretion, the institutional investor has committed to invest up to $20 million in the Company's common stock over a 30-month period. The Company filed a registration statement with the U.S. Securities and Exchange Commission covering the resale of the shares that may be issued to the institutional investor. The institutional investor is obligated to make purchases as the Company directs in accordance with the agreement, which may be terminated by the Company at any time, without cost or penalty. Sales of shares will be made in specified amounts and at prices that are based upon the market prices of the Company's common stock immediately preceding the sales to the institutional investor. The Company has issued 150,830 shares of common stock to the institutional investor as an initial commitment fee valued at $162,896, fair value and 301,659 shares of common stock are reserved for additional commitment fees to the institutional investor in accordance with the terms of the agreement. During June 2011 through December, 2013, the institutional investor purchased 5,352,671 shares of common stock for proceeds of $6,849,998. The Company issued 103,330 shares of common stock as additional commitment fee, valued at $168,556, fair value, leaving 198,329 in reserve for additional commitment fees. For the year ending December 31, 2013, the institutional investor purchased 1,628,386 shares of common stock for proceeds of $1,800,000 and the Company issued 27,153 shares of common stock as additional commitment fee, valued at $34,274, fair value. For the year ending December 31, 2012, the institutional investor purchased 3,539,100 shares of common stock for proceeds of $4,849,999 and the Company issued 73,160 shares of common stock as additional commitment fee, valued at $130,813, fair value.

	In August 2011, the board of directors approved a grant to a new employee of an option to purchase up to 150,000 shares of common stock at a purchase price of $1.01 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $123,241, fair value. The option expires in 5 years and vests in equal quarterly installments of 12,500 over the next 3 years beginning November 1, 2011. The expense recognized during 2012 and 2011 is $41,156 and $17,204. In August 2013, options to purchase 62,500 shares of common stock forfeited. For the year ending December 31, 2013, the Company recognized net expense of $13,531. During October 2013, 38,350 options were exercised for proceeds of $38,734 and the remaining 49,150 options forfeited.

	During February 2012, the Company issued 1,406 shares of common stock to a director serving as a member of the Company's Operations Committee valued at $1,607, fair value. For the year ending December 31, 2013 and 2012, the Company recognized $0 and $1,607 of expense.

	In March 2012, the board of directors approved a grant to an employee of an option to purchase up to 100,000 shares of common stock at a purchase price of $1.69 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $168,909, fair value. The option expires in 10 years and vests 25,000 immediately and the remaining vest 25,000 in six months, nine months and twelve months from date of grant. The option is expensed over the vesting terms. For the year ending December 31, 2013 and 2012, the Company recognized $29,154 and $139,755 of expense. As of December 31, 2013, option to purchase 100,000 shares of common stock are still outstanding.



	In March 2012, the board of directors approved a grant to an employee of an option to purchase up to 25,000 shares of common stock at a purchase price of $1.69 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $42,227, fair value. The option expires in 10 years with 12,500 vesting immediately and 12,500 vesting in six months from date of grant. The option is expensed over the vesting terms. For the year ending December 31, 2013 and 2012, the Company recognized $0 and $42,227 of expense. As of December 31, 2013, option to purchase 25,000 shares of common stock are still outstanding.

	In March 2012, the Company issued a warrant to purchase up to 10,000 shares of common stock for legal services at an exercise price of $1.69 per share. Using the Black-Scholes Option Pricing Formula, the warrants were valued at $13,709, fair value. These warrants expire in 5 years and vest immediately and are being expensed over the service period. For the year ending December 31, 2013 and 2012, the Company recognized $0 and $13,709 of expense. As of December 31, 2013, warrant to purchase 10,000 shares of common stock are still outstanding.

	In May, 2012, the board of directors appointed its current Non-Executive Chairman of the board of directors as its new Chief Executive Officer and Executive Chairman of the board of directors and approved a grant of an option to purchase up to 500,000 shares of common stock at a purchase price of $1.30 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $613,805, fair value. The option expires in 10 years and vests quarterly over one year in equal installments of 125,000 shares per quarter commencing on date of grant. The option is expensed over the vesting terms. For the year ending December 31, 2013 and 2012, the Company recognized $151,350 and $462,455 of expense. As of December 31, 2013, option to purchase 500,000 shares of common stock are still outstanding.

	During May 2012, the Company issued warrants to purchase 100,000 shares of common stock at a purchase price of $1.20 per share for accounting services rendered commencing May 1, 2012. The warrant was valued at $97,386 using the Black-Scholes Option Pricing Formula, vesting in thirteen monthly installments with 3,846 vesting at the beginning of each of the succeeding twelve months commencing June 1, 2012 and 3,848 the thirteenth month expiring in 5 years. The expense is being recognized based on service terms of the agreement over a fourteen-month period. For the year ending December 31, 2013 and 2012, the Company recognized $41,738 and $55,648 of expense. As of December 31, 2013, warrants to purchase 100,000 shares of common stock are still outstanding.

	In June 2012, the board of directors appointed a new member of the board of directors and approved a grant of an option to purchase up to 200,000 shares of common stock at a purchase price of $0.90 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $145,150, fair value. The option expires in 5 years and vests 50,000 immediately and the remaining in annual equal installments of 50,000 over the next three years. The option is expensed over the vesting terms. For the year ending December 31, 2013 and 2012, the Company recognized $36,287 and $56,568 of expense. As of December 31, 2013, option to purchase 200,000 shares of common stock are still outstanding.

	In August 2012, the board of directors approved a grant to a new employee of an option to purchase up to 100,000 shares of common stock at a purchase price of $0.925 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $74,486, fair value. The option expires in 5 years with 12,500 vesting every 3 months from date of grant. The option is expensed over the vesting terms. For the years ending December 31, 2013 and 2012, the Company recognized $37,242 and $15,611 of expense. As of December 31, 2013, options to purchase 100,000 shares of common stock are still outstanding. In February 2014, the option to purchase 25,000 shares of common stock forfeited.

	In August 2012, the board of directors approved a grant to a new employee of an option to purchase up to 50,000 shares of common stock at a purchase price of $0.93 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $37,486, fair value. The option expires in 5 years with 6,250 vesting every three months from date of grant. The option is expensed over the vesting terms. For the year ending December 31, 2012, the Company recognized $7,137 of expense. In July 2013, the option to purchase 31,250 shares of common stock forfeited. For the year ending December 31, 2013, the Company recognized net expense of $6,920. In October 2013, the option to purchase 18,750 shares of common stock forfeited.

	Effective August 24, 2012, the number of shares of the Company's common stock available for issuance under the 2007 Employee Stock plan was increased from 6,500,000 to 8,000,000 shares.

	In December 2012, the board of directors approved a grant to a senior advisor of a warrant to purchase up to 125,000 shares of common stock at a purchase price of $0.93 per share. Using the Black-Scholes Option Pricing Formula, the warrant was valued at $97,692, fair value. The warrant expires in 5 years with 31,256 vesting immediately and 7,812 vesting every month from date of grant. The warrant is expensed over the vesting terms. For the year ending December 31, 2013 and 2012, the Company recognized $69,455 and $28,237 of expense. As of December 31, 2013, warrant to purchase 125,000 shares of common stock is still outstanding.

	In March 2013, the board of directors approved a grant to a new employee of an option to purchase up to 75,000 shares of common stock at a purchase price of $1.16 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $81,076, fair value. The option expires in 10 years with 9,375 vesting quarterly from date of grant. The option is expensed over the vesting terms. For the year ending December 31, 2013, the Company recognized $33,986 of expense. As of December 31, 2013, options to purchase 75,000 shares of common stock are still outstanding.

	In May 2013, the board of directors approved a grant to a new employee of an option to purchase up to 10,000 shares of common stock at a purchase price of $1.03 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $9,574, fair value. The option expires in 10 years with 1,250 vesting quarterly from date of grant. The option is expensed over the vesting terms. In December 2013, the option to purchase 7,500 shares of common stock forfeited. For the year ending December 31, 2013, the Company recognized a net expense of $2,394. As of December 31, 2013, options to purchase 2,500 shares of common stock are still outstanding. In March 2014, the options to purchase 2,500 shares of common stock forfeited.

	In May 2013, the board of directors approved a grant to an employee of an option to purchase up to 100,000 shares of common stock at a purchase price of $1.00 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $80,824, fair value. The option expires in 10 years with 25,000 vesting August 1, 2013, October 1, 2013 and quarterly thereafter. The option is expensed over the vesting terms. For the year ending December 31, 2013, the Company recognized $60,399 of expense. As of December 31, 2013, options to purchase 100,000 shares of common stock are still outstanding.



	In June 2013, the Company signed a Purchase Agreement and Registration Rights Agreement with an institutional investor to sell up to $20 million of common stock. Under the agreement subject to certain conditions and at the Company's sole discretion, the institutional investor has committed to invest up to $20 million in the Company's common stock over a 30-month period. The Company filed the registration statement with the U.S. Securities and Exchange Commission in September 2013. The institutional investor is obligated to make purchases as the Company directs in accordance with the agreement, which may be terminated by the Company at any time, without cost or penalty. Sales of shares will be made in specified amounts and at prices that are based upon the market prices of the Company's common stock immediately preceding the sales to the institutional investor. The Company issued 200,000 shares of restricted common stock to the institutional investor as an initial commitment fee valued at $170,000, fair value and 400,000 shares of common stock are reserved for additional commitment fees to the institutional investor in accordance with the terms of the agreement. During October and November 2013, the institutional investor purchased 500,000 shares of common stock for proceeds of $478,500. During October and November 2013, the Company issued 7,642 shares of common stock as additional commitment fee, valued at $7,882, fair value, leaving 392,358 in reserve for additional commitment fees. During February 2014, the institutional investor purchased 200,000 shares of common stock for proceeds of $177,660. During February 2014, the Company issued 2,680 shares of common stock as additional commitment fee, valued at $2,741, fair value, leaving 389,678 in reserve for additional commitment fees.

	During July 2013, the Company issued a warrant to purchase 100,000 shares of common stock at a purchase price of $0.90 per share for accounting services rendered commencing July 1, 2013. The warrant was valued at $48,915 using the Black-Scholes Option Pricing Formula, vesting over the next twelve months with 8,333 vesting each month for the first eleven months and 8,337 vesting the twelfth month from date of grant. The warrant expires in five years. The expense is being recognized based on service terms of the agreement over a twelve month period. For the year ending December 31, 2013, the Company recognized $24,658 of expense. As of December 31, 2013, warrant to purchase 100,000 shares of common stock is still outstanding.

During August 2013, the Company issued an option to an employee to purchase 25,000 shares of common stock at a purchase price of $0.84 per share. The option was valued at $17,852 using the Black-Scholes Option Pricing Formula. The option expires in ten years and vests immediately. The option is expensed over the vesting terms. For the year ending December 31, 2013, the Company recognized $17,852 of expense. As of December 31, 2013, the option to purchase 25,000 shares of common stock is still outstanding.

During August 2013, the Company issued an option to a director to purchase 50,000 shares of common stock at a purchase price of $0.84 per share. The option was valued at $35,704 using the Black-Scholes Option Pricing Formula, vesting 20,000 options immediately and 10,000 options vesting in three equal quarterly installments commencing October 1, 2013. The option expires in ten years. The option is expensed over the vesting terms. For the year ending December 31, 2013, the Company recognized $28,485 of expense. As of December 31, 2013, the option to purchase 50,000 shares of common stock is still outstanding.



In October 2013, the Company issued an option to a new director to purchase 200,000 shares of common stock at a purchase price of $0.93 per share for a directorship commencing November 1, 2013. The option was valued at $174,106 using the Black-Scholes option pricing model. The option expires in 10 years with 50,000 vesting in annual installments commencing November 1, 2013. The option is expensed over the vesting terms. For the year ending December 31, 2013, the Company recognized $50,801 of expense. As of December 31, 2013, the option to purchase 200,000 shares of common stock is still outstanding.

STOCK_BASED_COMPENSATION

STOCK BASED COMPENSATION	12 Months Ended
STOCK BASED COMPENSATION	Dec. 31, 2013
STOCK BASED COMPENSATION [Abstract]	'
STOCK BASED COMPENSATION	'
	NOTE 8 - STOCK BASED COMPENSATION

	The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award, with the following assumptions for 2013 and 2012: no dividend yield in both years, expected volatility, based on the Company's historical volatility, 107% to 113% in 2013 and between 77% and 217% in 2012, risk-free interest rate between 0.94% to 1.86% in 2013 and between 0.13% and 2.26% in 2012 and expected option life of 3 to 10 years in 2013 and 2 to 10 years in 2012.

	As of December 31, 2013, there was $384,591 of unrecognized compensation expense related to non-vested market-based share awards that is expected to be recognized through October 2016.

	The following tables summarize all stock option and warrant activity of the Company during the year ended December 31, 2013 and 2012:

		Non-Qualified Stock Options
		and Warrants Outstanding and Exercisable
							Weighted
		Number of			Exercise		Average
		Shares			Price		Exercise Price

	Outstanding, December 31, 2011		8,798,500			$0.25 - $1.75	$	1.02

	Granted		1,210,000			$0.90 - $1.69	$	1.19
	Expired		(25,000	)		$1.25	$	1.25
	Forfeited					-		-
	Exercised		(1,210,000	)		$0.25 - $1.25	$	0.37

	Outstanding, December 31, 2012		8,773,500			$0.25 - $1.75	$	1.13

	Granted		560,000			$0.84 - $1.16	$	0.96
	Expired		(1,971,650	)		$0.73 - $1.25	$	1.02
	Forfeited		(120,000	)		$0.93 - $1.03	$	0.99
	Exercised		(95,850	)		$0.345 - $1.25	$	0.76

	Outstanding, December 31, 2013		7,146,000			$0.25 - $1.75	$	1.16

	Exercisable, December 31, 2013		6,529,123			$0.25 - $1.75	$	1.18

	Non-Qualified Stock Options and Warrants Outstanding
		Number Outstanding		Weighted Average	Weighted Average
	Range of	Currently Exercisable		Remaining	Exercise Price of Options and
	Exercise Prices	at December 31, 2013		Contractual Life	Warrants Currently Exercisable

	$0.25 - $1.75	6,529,123		2.82	$1.18

RELATED_PARTY

RELATED PARTY	12 Months Ended
RELATED PARTY	Dec. 31, 2013
RELATED PARTY [Abstract]	'
RELATED PARTY	'
	NOTE 9 - RELATED PARTY

	At December 31, 2013 the Company had accrued salaries to two beneficial owners of $42,088, legal accrual to related party of $5,500 and travel and office expense accruals of officers in the amount of $1,229. At December 31, 2012 the Company had accrued salaries to two beneficial owners of $48,650, legal accrual to related party of $3,600 and travel and office expense accruals of officers in the amount of $3,356.

RETIREMENT_PLAN

RETIREMENT PLAN	12 Months Ended
RETIREMENT PLAN	Dec. 31, 2013
RETIREMENT PLAN [Abstract]	'
RETIREMENT PLAN	'
	NOTE 10 - RETIREMENT PLAN

	During 2013, the Company established a 401(k) retirement plan covering all eligible employees beginning November 15, 2013. There were no contributions charged to expense.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2013
SUBSEQUENT EVENTS [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 11 - SUBSEQUENT EVENTS

	In December 2013, the board of directors approved a grant to a senior advisor effective January 2014 of a warrant to purchase up to 100,000 shares of common stock at a purchase price of $0.715 per share. Using the Black-Scholes Option Pricing Formula, the warrant was valued at $53,313, fair value. The warrant expires in 5 years and vests 25,000 immediately and the remaining in equal monthly installments of 7,500 over the next 10 months. The warrant is expensed over the vesting terms.

	In January 2014, the Company issued options to the Company's 4 independent directors to each purchase 50,000 shares of common stock at a purchase price of $0.715 per share. The options were each valued at $29,440 using the Black-Scholes Option Pricing Formula. The options expire in 10 years with 20,000 vesting immediately and the remainder vesting in quarterly equal installments of 10,000 commencing April 1, 2014. The options are expensed over the vesting terms.

	In March 2014, the Company issued options to a new employee to purchase 30,000 shares of common stock at a purchase price of $0.92 per share. The options were valued at $23,865 using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 3,750 from date of employment. The options are expensed over the vesting terms.



	In March 2014, the Company issued options to a new employee to purchase 75,000 shares of common stock at a purchase price of $0.92 per share. The options were valued at $59,792 using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 9,375 from date of employment. The options are expensed over the vesting terms.

	In March 2014, the Company issued options to a new employee to purchase 50,000 shares of common stock at a purchase price of $0.92 per share. The options were valued at $39,862 using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 6,250 from date of employment. The options are expensed over the vesting terms.

	In March 2014, the Company issued options to an employee to purchase 125,000 shares of common stock at a purchase price of $0.92 per share. The options were valued at $98,565 using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 15,625 commencing April 1, 2014. The options are expensed over the vesting terms.

	In March 2014, the Company issued options to an employee to purchase 30,000 shares of common stock at a purchase price of $0.92 per share. The options were valued at $22,771 using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 7,500 commencing April 1, 2014. The options are expensed over the vesting terms.

	In March 2014, the Company issued options to purchase 40,000 shares of common stock at a purchase price of $0.92 per share to its Chief Executive Officer as part of a new employment agreement. The options were valued at $30,362 using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 10,000 commencing April 1, 2014. The options are expensed over the vesting terms.

	In March 2014, the Company issued warrants to purchase 100,000 shares of common stock for consulting services at an exercise price of $0.92 per share. The warrants were valued at $66,936 using the Black-Scholes Option Pricing Formula. The warrants expire in 5 years vesting 25,000 immediately with the remaining 75,000 vesting in monthly equal installments of 7,500 commencing April 1, 2014. The warrants are expensed over the vesting terms.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
History and Nature of Business	'
	History and Nature of Business
	Lightwave Logic, Inc., formerly Third-Order Nanotechnologies, Inc., formerly PSI-Tec Holdings, Inc., formerly Eastern Idaho Internet Service, Inc. (the "Company") was organized under the laws of the State of Nevada in 1997. The Company was engaged in the business of marketing internet services until June 30, 1998, at which time the principal assets of the business were sold and operations were discontinued. The Company was inactive until the acquisition of PSI-TEC Corporation ("PSI-TEC") on July 14, 2004, at which time the name was changed to PSI-TEC Holdings, Inc.
Development Stage	'
	Development Stage
	PSI-TEC was incorporated in 1995 under the laws of the State of Delaware. PSI-TEC primarily conducted research for the United States Government under a contract, which expired in 2003. Beginning January 1, 2004, PSI-TEC was engaged in the development of electro-optic polymers for application in the electro-optic device markets. PSI-TEC is considered a development stage company as defined in Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 "Development Stage Entities" from the inception of the development stage on January 1, 2004.
Merger	'
	Merger
	On July 14, 2004, the Company acquired PSI-TEC. Under the terms of the merger agreement, the stockholders of PSI-TEC received 15,600,000 shares of common stock in exchange for its 2,206,280 shares. Following the merger, the Company changed its name to PSI-TEC Holdings, Inc. Under accounting principles generally accepted in the United States, the share exchange is considered to be a capital transaction in substance rather than a business combination. That is, the share exchange is equivalent to the issuance of stock by PSI-TEC Holdings, Inc. for the net monetary assets of PSI-TEC, accompanied by a recapitalization, and is accounted for as a change of capital structure. Accordingly, the accounting for the share exchange was identical to that resulting from a reverse acquisition, except no goodwill was recorded. Under reverse takeover accounting, the post-reverse acquisition comparative historical financial statements of the legal acquirer, PSI-TEC Holdings, Inc., are those of the legal acquiree, PSI-TEC, which is considered to be the accounting acquirer. On October 20, 2006, PSI-TEC Holdings, Inc. and PSI-TEC merged and changed its name to Third-Order Nanotechnologies, Inc. On March 10, 2008, Third-Order Nanotechnologies, Inc. changed its name to Lightwave Logic, Inc.
Basis of Presentation	'
	Basis of Presentation
	The financial statements are presented in accordance with Financial Accounting Standards Board of Accounting Standards Codification ("FASB ASC") 915 for development stage companies. The accompanying financial statements are presented in accordance with accounting principles generally accepted in the United States of America.
Estimates	'
	Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management's best knowledge of current events and actions the Company may undertake in the future, actual results could differ from the estimates.
Cash Equivalents	'
	Cash Equivalents
	For the purposes of the statement of cash flows, the Company considers all highly liquid instruments with maturities of three months or less at the time of purchase to be cash equivalents.
Concentration of Credit Risk	'
	Concentration of Credit Risk
	Certain financial instruments potentially subject the Company to concentrations of credit risk. These financial instruments consist primarily of cash. At December 31, 2013, the Company did have deposits with a financial institution that exceed the Federal Depository Insurance coverage.
Property and Equipment	'
	Property and Equipment
	Equipment is stated at cost. Depreciation is principally provided by use of straight-line methods for financial and tax reporting purposes over the estimated useful lives of the assets, generally 5 years. When property is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in operations.
Intangible Assets	'
	Intangible Assets
	Definite-lived intangible assets are stated at cost. Patents are amortized over their estimated useful lives, generally 20 years. When certain patent applications are abandoned by the Company for claims that are covered by patents already granted to the Company, the cost of patent applications and accumulated amortization are removed from the accounts and the resulting expense is reflected in the Statement of Operations.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company's financial instruments consist of cash, accounts payable and accrued expenses. The carrying values of cash, accounts payable and accrued expenses approximate fair value because of their short maturities.
Income Taxes	'
	Income Taxes
	The Company follows FASB ASC 740, "Income Taxes," which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.
Loss Per Share	'
	Loss Per Share
	The Company follows FASB ASC 260, "Earnings per Share", resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss in 2013 and 2012, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.
Recoverability of Long Lived Assets	'
	Recoverability of Long Lived Assets
	The Company follows FASB ASC 360, "Property, Plant, and Equipment". Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the related carrying amount may not be recoverable. When required, impairment losses on assets to be held and used are recognized based on the excess of the asset's carrying amount.
Comprehensive Income	'
	Comprehensive Income
	The Company follows FASB ASC 220.10, "Reporting Comprehensive Income." Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since the Company has no items of other comprehensive income, comprehensive income (loss) is equal to net loss.
Recently Adopted Accounting Pronouncements	'
	Recently Adopted Accounting Pronouncements
	As of December 31, 2013 and for the year then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company's financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted	'
	Recently Issued Accounting Pronouncements Not Yet Adopted
	As of December 31, 2013, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.

PROPERTY_AND_EQUIPMENT_Tables

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
PROPERTY AND EQUIPMENT (Tables)	Dec. 31, 2013
PROPERTY AND EQUIPMENT [Abstract]	'
Schedule of Property and Equipment	'
	Equipment consists of the following:

		December 31,		December 31,
		2013		2012

	Office equipment	$	24,244	$	12,741
	Lab equipment		474,049		388,521
	Furniture		4,061		4,061
	Leasehold improvements		37,519		28,134
			539,873		433,457
	Less: Accumulated depreciation		241,513		132,463

		$	298,360	$	300,994

INTANGIBLE_ASSETS_Tables

INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2013
INTANGIBLE ASSETS [Abstract]	'
Schedule of Patents	'
	Patents consists of the following:

		December 31,		December 31,
		2013		2012

	Patents	$	579,235	$	509,360
	Less: Accumulated amortization		35,695		20,834

		$	543,540	$	488,526

COMMITMENTS_Tables

COMMITMENTS (Tables)	12 Months Ended
COMMITMENTS (Tables)	Dec. 31, 2013
Office Building [Member]	'
Operating Lease [Line Items]	'
Schedule of Future Lease Payments of Operating Leases	'
	The aggregate minimum future lease payments under the operating leases are as follows:



	DECEMBER 31,	AMOUNT

	2014	$	28,025
	2015		46,038
	2016		47,407
	2017		48,817
	Thereafter		56,581
	TOTAL	$	226,868

Laboratory Space [Member]	'
Operating Lease [Line Items]	'
Schedule of Future Lease Payments of Operating Leases	'
	Aggregate minimum future lease payments under the operating leases are as follows:

	YEAR ENDING
	DECEMBER 31,	AMOUNT

	2014	$	22,708

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Dec. 31, 2013
INCOME TAXES [Abstract]	'
Schedule of Income Tax Benefit (Provision)	'
	The income tax benefit (provision) consists of the following:

		2013			2012

	Current	$	(1,345,000	)	$	(1,563,000	)
	Deferred		(370,000	)		(576,000	)
	Change in valuation allowance		1,715,000			2,139,000


		$	-		$	-
Schedule of Reconciliation of Statutory Federal Rate to Effective Income Tax Rate	'
	The reconciliation of the statutory federal rate to the Company's effective income tax rate is as follows:

		2013						2012

		Amount			%			Amount			%
	Income tax benefit at U.S.
	federal income tax rate	$	(1,330,000	)		(34	)	$	(1,549,000	)		(34	)
	State tax, net of federal tax effect		(352,000	)		(9	)		(410,000	)		(9	)
	Non-deductible share-based compensation		(33,000	)		(1	)		(180,000	)		(4	)
	Change in valuation allowance		1,715,000			44			2,139,000			47

		$	-			-		$	-			-

Schedule of Components of Deferred Tax Assets	'
	The components of deferred tax assets as of December 31, 2013, and December 31, 2012 are as follows:

		2013			2012

	Deferred tax asset for NOL carryforwards	$	9,992,000		$	8,647,000
	Share-based compensation		3,335,000			2,966,000
	Accrued expenses		17,000			17,000
	Valuation allowance		(13,344,000	)		(11,630,000	)

		$	-		$	-

STOCK_BASED_COMPENSATION_Table

STOCK BASED COMPENSATION (Tables)	12 Months Ended
STOCK BASED COMPENSATION (Tables)	Dec. 31, 2013
STOCK BASED COMPENSATION [Abstract]	'
Schedule of Non-Qualified Stock Options and Warrants Outstanding and Exercisable	'
	The following tables summarize all stock option and warrant activity of the Company during the year ended December 31, 2013 and 2012:

		Non-Qualified Stock Options
		and Warrants Outstanding and Exercisable
							Weighted
		Number of			Exercise		Average
		Shares			Price		Exercise Price

	Outstanding, December 31, 2011		8,798,500			$0.25 - $1.75	$	1.02

	Granted		1,210,000			$0.90 - $1.69	$	1.19
	Expired		(25,000	)		$1.25	$	1.25
	Forfeited					-		-
	Exercised		(1,210,000	)		$0.25 - $1.25	$	0.37

	Outstanding, December 31, 2012		8,773,500			$0.25 - $1.75	$	1.13

	Granted		560,000			$0.84 - $1.16	$	0.96
	Expired		(1,971,650	)		$0.73 - $1.25	$	1.02
	Forfeited		(120,000	)		$0.93 - $1.03	$	0.99
	Exercised		(95,850	)		$0.345 - $1.25	$	0.76

	Outstanding, December 31, 2013		7,146,000			$0.25 - $1.75	$	1.16

	Exercisable, December 31, 2013		6,529,123			$0.25 - $1.75	$	1.18
Schedule of Non-Qualified Stock Options and Warrants Outstanding, by Exercise Price Range	'

	Non-Qualified Stock Options and Warrants Outstanding
		Number Outstanding		Weighted Average	Weighted Average
	Range of	Currently Exercisable		Remaining	Exercise Price of Options and
	Exercise Prices	at December 31, 2013		Contractual Life	Warrants Currently Exercisable

	$0.25 - $1.75	6,529,123		2.82	$1.18

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)	12 Months Ended	90 Months Ended	204 Months Ended
	Dec. 31, 2013	Jul. 13, 2004	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'	'	'
Estimated useful life of patents	'20 years	'	'
Date of incorporation	1-Jan-97	1-Jan-97	'
Entity former incorporation name	'Third-Order Nanotechnologies, Inc., formerly PSI-Tech Holdings, Inc., formerly Eastern Idaho Internet Services, Inc.	'PSI-Tech Holdings, Inc.	'
Jurisdiction of incorporation	'Nevada	'Nevada	'
Date of corporate name change	'2008-03-10	'	'2008-03-10
Disposal of assets discription	'	'The Company was engaged in the business of marketing internet services until June 30, 1998, at which time the principal assets of the business were sold and operations were discontinued.	'
Date of acquisition	'	'	14-Jul-04
Fair value method for acquisition transaction	'	'	'The share exchange is considered to be a capital transaction in substance rather than a business combination. That is, the share exchange is equivalent to the issuance of stock by PSI-TEC Holdings, Inc. for the net monetary assets of PSI-TEC, accompanied by a recapitalization, and is accounted for as a change of capital structure. Accordingly, the accounting for the share exchange was identical to that resulting from a reverse acquisition, except no goodwill was recorded. Under reverse takeover accounting, the post-reverse acquisition comparative historical financial statements of the legal acquirer, PSI-TEC Holdings, Inc.
Name of acquired entity	'	'	'PSI-TEC
Common shares issued by entity in acquisition transaction	'	'	15,600,000
Common shares exchanged	'	'	2,206,280
Date of merger	'	'	'2006-10-20

MANAGEMENTS_PLANS_Details

MANAGEMENT'S PLANS (Details) (USD $)	12 Months Ended
MANAGEMENT'S PLANS (Details) (USD $)	Dec. 31, 2013	Jun. 30, 2013
MANAGEMENT'S PLANS [Abstract]	'	'
Approximate cash position	'	$2,000,000
Approximate monthly expenditures	270,000	'
Agreement with an institutional investor to sell common stock and investor committed to invest in common stock (upper limit)	20,000,000	'
Remaining available amount	19,343,840	'
Debt Service	'	'
Operational Funding	'2014-09	'
Number of options outstanding for additional funding	'	1,441,000
Exercise price of option one	'	0.34
Exercise price of option two	'	0.72
Estimated proceeds from options exercises	$873,000	'
Warrants expiration date	'2014	'

PROPERTY_AND_EQUIPMENT_Schedul

PROPERTY AND EQUIPMENT (Schedule of Equipment) (Details) (USD $)	Jun. 30, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	$539,873	$433,457
Less: Accumulated depreciation	241,513	132,463
Property and equipment, net	298,360	300,994
Office equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	24,244	12,741
Lab equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	474,049	388,521
Furniture [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	4,061	4,061
Leasehold improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	$37,519	$28,134

PROPERTY_AND_EQUIPMENT_Narrati

PROPERTY AND EQUIPMENT (Narrative) (Details) (USD $)	12 Months Ended
PROPERTY AND EQUIPMENT (Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
PROPERTY AND EQUIPMENT [Abstract]	'	'
Depreciation expense	$111,912	$53,391

INTANGIBLE_ASSETS_Schedule_of_

INTANGIBLE ASSETS (Schedule of Patents) (Details) (USD $)	Jun. 30, 2013	Dec. 31, 2012
INTANGIBLE ASSETS [Abstract]	'	'
Patents	$579,235	$509,360
Less: Accumulated amortization	35,695	20,834
Intangible assets - net	$543,540	$488,526

INTANGIBLE_ASSETS_Narrative_De

INTANGIBLE ASSETS (Narrative) (Details) (USD $)	12 Months Ended
INTANGIBLE ASSETS (Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
INTANGIBLE ASSETS [Abstract]	'	'
Estimated useful life of patents	'20 years	'
Amortization expense	$14,861	$12,151
Expense for abandoned patents	'	$13,675

COMMITMENTS_Details

COMMITMENTS (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013	Jun. 30, 2013
	Dec. 31, 2013	Dec. 31, 2012	Office building [Member]	Laboratory space [Member]
Operating Lease [Line Items]	'	'	'	'
2014	'	'	$28,025	$22,708
2015	'	'	46,038	'
2016	'	'	47,407	'
2017	'	'	48,817	'
Thereafter	'	'	56,581	'
Total future minimum lease payments	'	'	226,868	'
Rent expense included in research and development	$68,125	$53,563	'	'
Opearating lease expiration period	'5 years	'	'	'

INCOME_TAXES_Narrative_Details

INCOME TAXES (Narrative) (Details) (USD $)	12 Months Ended
INCOME TAXES (Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013
INCOME TAXES [Abstract]	'	'	'
Deferred tax assets valuation allowance	'	$11,630,000	$13,344,000
Change in valuation allowance	1,715,000	2,139,000	'
Net operating loss carry forwards	'	'	$23,200,000
Net operating loss carry forwards expiration date	31-Dec-33	'	'

INCOME_TAXES_Schedule_of_Incom

INCOME TAXES (Schedule of Income Tax Benefit (Provision)) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
INCOME TAXES [Abstract]	'	'
Current	($1,345,000)	($1,563,000)
Deferred	-370,000	-576,000
Change in valuation allowance	1,715,000	2,139,000
Total	'	'

INCOME_TAXES_Schedule_of_Recon

INCOME TAXES (Schedule of Reconciliation of Statutory Federal Rate to Effective Income Tax Rate) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
INCOME TAXES [Abstract]	'	'
Income tax benefit at U.S. federal income tax rate	-34.00%	-34.00%
State tax, net of federal tax effect	-9.00%	-9.00%
Non-deductible share-based compensation	-1.00%	-4.00%
Change in valuation allowance	44.00%	47.00%
Total	'	'
Income tax benefit at U.S. federal income tax rate	($1,330,000)	($1,549,000)
State tax, net of federal tax effect	-352,000	-410,000
Non-deductible share-based compensation	-33,000	-180,000
Change in valuation allowance	1,715,000	2,139,000
Total	'	'

INCOME_TAXES_Schedule_of_Compo

INCOME TAXES (Schedule of Components of Deferred Tax Assets) (Details) (USD $)	Jun. 30, 2013	Dec. 31, 2012
INCOME TAXES [Abstract]	'	'
Deferred tax asset for NOL carryforwards	$9,992,000	$8,647,000
Stock-based compensation	3,335,000	2,966,000
Accrued expenses	17,000	17,000
Valuation allowance	-13,344,000	-11,630,000
Total	'	'

STOCKHOLDERS_EQUITY_Details

STOCKHOLDERS' EQUITY (Details) (USD $)

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

31 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

Oct. 31, 2013

Dec. 31, 2013

Dec. 31, 2011

Jan. 31, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2010

Jan. 31, 2013

Dec. 31, 2010

Sep. 30, 2013

Dec. 31, 2010

Mar. 31, 2013

Aug. 31, 2012

Apr. 30, 2012

Sep. 30, 2011

Dec. 31, 2010

Dec. 31, 2008

Dec. 31, 2007

Jul. 31, 2013

Apr. 30, 2007

Mar. 31, 2007

Apr. 30, 2012

Apr. 30, 2010

Jul. 31, 2008

Dec. 31, 2008

Dec. 31, 2007

Apr. 30, 2007

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

31-May-12

Dec. 31, 2008

Apr. 30, 2008

Jun. 30, 2013

Feb. 29, 2012

Apr. 30, 2010

Jun. 30, 2009

Dec. 31, 2010

Dec. 31, 2009

Mar. 31, 2014

Jul. 31, 2013

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2010

Jun. 30, 2013

31-May-11

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Feb. 28, 2014

Oct. 31, 2013

Aug. 31, 2013

Aug. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Oct. 31, 2013

Jul. 31, 2013

Aug. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2013

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2013

31-May-13

31-May-12

Dec. 31, 2013

Mar. 31, 2014

31-May-13

Dec. 31, 2013

Jun. 30, 2013

Aug. 31, 2013

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2013

31-May-10

Jan. 31, 2009

Dec. 31, 2009

Jun. 30, 2013

Jan. 31, 2014

Feb. 28, 2009

Dec. 31, 2009

Aug. 31, 2013

Dec. 31, 2013

Jun. 30, 2013

Oct. 31, 2013

Dec. 31, 2013

Jun. 30, 2013

Feb. 29, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

Jan. 31, 2014

Jun. 30, 2012

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

31-May-12

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

Mar. 31, 2014

Aug. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

Feb. 28, 2014

Aug. 31, 2012

Jan. 31, 2012

Nov. 30, 2008

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Warrant agreement amendment [Member]

Common stock and warrants [Member]

Common Stock [Member]

Warrants [Member]

Warrant Two [Member]

Warrant Transaction for Management Consulting Serices [Member]

Warrant Transaction for Consulting Services [Member]

Warrant Transaction for Legal Services [Member]

Warrant Transaction for Accounting Services [Member]

Warrant Transaction for Consulting Services 2 [Member]

Warrant Transaction for Accounting Services 2 [Member]

Warrant Transaction for Accounting Services 3 [Member]

Unit Components [Member]

Institutional Investor [Member]

August 2011 New Employee [Member]

August 2012 New Employee [Member]

March 2013 New Employee 1 [Member]

May 2013 New Employee 1 [Member]

May 2013 New Employee 2 [Member]

August 2013 New Employee [Member]

January 2009 New Employee [Member]

February 2009 New Employee [Member]

August 2013 Director [Member]

October 2013 Director [Member]

February 2012 Director [Member]

Senior Advisor [Member]

June 2012 Director [Member]

March 2012 New Employee [Member]

March 2012 New Employee 2 [Member]

CEO [Member]

August 2012 New Employee 2 [Member]

2007 Employee Stock Plan [Member]

Subsequent Event [Member]

Equity Issuance [Line Items]

Number of common shares that can be purchased through warrant

400,000

100,000

500,000

1,000,000

900,000

100,000

10,000

100,000

600,000

464,000

100,000

Exercise price of warrants

0.73

0.9

0.25

0.92

1.69

1.2

0.73

0.34

0.9

0.715

Fair value of warrant

$4,815

$348,000

$580,000

$604,416

$66,936

$13,709

$97,386

$976,193

$391,342

$48,915

$53,313

Shares rescinded/forfeited

400,000

200,000

178,750

49,150

62,500

18,750

31,250

7,500

2,500

25,000

Warrant expiration date

31-Oct-13

30-Sep-11

31-Dec-11

30-Jun-13

31-Mar-13

30-Sep-12

Warrant expiration date, transaction two

30-Sep-13

30-Jun-13

31-Dec-12

Warrant expiration extention

'3 months

'6 months

'1 year

Warrant expiration date, number of shares

143,750

335,000

Stock issued to purchase common stock, warrants and monetary compensation

1,500,000

Number of shares purchased

12,500

40,000

375,000

156,250

218,750

400,000

100,000

500,000

380,000

20,000

10,000

250,000

500,000

1,628,386

3,539,100

5,352,671

200,000

15,000

10,000

250,000

Proceeds from issuance of common stock and warrants

15,625

1,500,000

50,000

100,000

25,000

125,000

95,000

20,000

6,900

3,450

86,250

478,500

1,800,000

4,849,999

6,849,998

177,660

38,734

11,250

3,750

2,500

162,500

Number of units offered (upper limit)

5,000

Price per unit

50,000

Number of shares comprising unit

50,000

Agreement with an institutional investor to sell common stock and investor committed to invest in common stock (upper limit)

20,000,000

2,680

Common stock issued to institutional investor as commitment fee, shares

200,000

7,642

27,153

73,160

150,830

103,330

2,741

Common stock issued to institutional investor as commitment fee

170,000

162,896

170,000

7,882

34,274

130,813

162,896

168,556

389,678

Common stock reserved for additional commitment fees to the institutional investor

400,000

392,354

301,659

198,329

Option granted, shares (upper limit)

150,000

50,000

75,000

10,000

100,000

25,000

50,000

200,000

1,406

125,000

200,000

100,000

25,000

500,000

40,000

100,000

800,000

250,000

Option granted, purchase price

$1.01

$0.93

$1.16

$1.03

$0.84

$0.25

$0.45

$0.84

$0.93

$0.90

$1.69

$1.30

$0.92

$0.93

$0.65

Option granted, value

123,241

37,486

81,076

9,574

80,824

17,852

13,136

9,583

35,704

174,106

1,607

97,692

145,150

168,909

42,227

613,805

30,362

74,486

125,911

Option granted, expiration date

'5 years

'10 years

'5 years

'10 years

Vesting immediately

25,000

46,400

20,000

31,256

25,000

50,000

25,000

12,500

62,500

Option granted, number of shares vesting in installments

7,500

23,200

12,500

6,250

9,375

1,250

25,000

10,000

50,000

7,812

7,500

50,000

25,000

12,500

125,000

10,000

12,500

62,500

Frequency of vesting installments

'Quarterly

'Monthly

'with 8,333 vesting each month for the first eleven months and 8,337 vesting the twelfth month from date of grant

'Quarterly

'Every 3 months

'Quarterly

'vesting in thirteen monthly installments with 3,846 vesting at the beginning of each of the succeeding twelve months commencing June 1, 2012 and 3,848 the thirteenth month expiring in 5 years.

'August 1, 2013, October 1, 2013 and quarterly thereafter

'Quarterly

'Annually

'Monthly

'Annual

'In 6 months, 9 months, and 12 months

'6 months from grant

'Quarterly

'Every 3 months

'Annually

Beginning date of shares vesting

1-Nov-11

1-Oct-13

1-Nov-13

Vesting period

'22 months

'12 months

'3 years

Plan duration

'5 years

'10 years

'5 years

'10 years

'5 years

'10 years

'5 years

Stock option expense

13,709

41,738

55,648

213,459

177,883

24,658

13,531

41,156

17,204

6,920

7,137

33,986

2,394

60,399

17,852

13,136

9,583

28,485

50,801

1,607

69,455

28,237

36,287

56,568

29,154

139,755

42,227

151,350

462,455

37,242

15,611

26,648

31,478

61,346

6,439

Stock exercised

38,350

Stock outstanding

10,000

100,000

414,000

100,000

75,000

100,000

25,000

10,000

50,000

200,000

125,000

200,000

100,000

25,000

500,000

100,000

Consulting Expense

$154,667

$773,333

$170,451

$433,966

$976,193

STOCK_BASED_COMPENSATION_Narra

STOCK BASED COMPENSATION (Narrative) (Details) (USD $)	12 Months Ended
STOCK BASED COMPENSATION (Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Expected dividend yield	'	'	'
Expected volatility, minimum	107.00%	77.00%	'
Expected volatility, maximum	113.00%	217.00%	'
Risk-free interest rate, minimum	0.94%	0.13%	'
Risk-free interest rate, maximum	1.86%	2.26%	'
Unrecognized compensation expense related to non-vested market-based share awards	'	'	$384,591
Expected to be recognized	'2 years 10 months	'	'
Minimum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Expected option life	'3 years	'2 years	'
Maximum [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Expected option life	'10 years	'10 years	'

STOCK_BASED_COMPENSATION_Sched

STOCK BASED COMPENSATION (Schedule of Stock Option and Warrant Outstanding and Exercisable)(Details) (USD $)	1 Months Ended	12 Months Ended
	Oct. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013
	Oct. 31, 2013	Non-Qualified Stock Options and Warrants [Member]	Non-Qualified Stock Options and Warrants [Member]	Non-Qualified Stock Options and Warrants [Member]
Number of Shares	'	'	'	'
Outstanding	'	8,773,500	8,798,500	7,146,000
Granted	'	560,000	1,210,000	'
Expired	'	-1,971,650	-25,000	'
Forfeited	-400,000	-120,000	'	'
Exercised	'	-95,850	-1,210,000	'
Outstanding	'	'	8,773,500	7,146,000
Exercisable	'	'	'	6,529,123
Exercise Price	'	'	'	'
Outstanding (Lower Limit)	'	$0.25	$0.25	'
Outstanding (Upper Limit)	'	$1.75	$1.75	'
Granted (Lower Limit)	'	$0.84	$0.90	'
Granted (Upper Limit)	'	$1.16	$1.69	'
Expired (Lower Limit)	'	$0.73	'	'
Expired	'	'	$1.25	'
Expired (Upper Limit)	'	$1.25	'	'
Forfeited (Lower Limit)	'	$0.93	'	'
Forfeited (Upper Limit)	'	$1.03	'	'
Exercised (Lower Limit)	'	$0.35	$0.25	'
Exercised (Upper Limit)	'	$1.25	$1.25	'
Outstanding (Lower Limit)	'	$0.25	$0.25	'
Outstanding (Upper Limit)	'	$1.75	$1.75	'
Exercisable (Lower Limit)	'	$0.25	'	'
Exercisable (Upper Limit)	'	$1.75	'	'
Weighted Average Exercise Price	'	'	'	'
Outstanding	'	$1.13	$1.02	$1.16
Granted	'	$0.96	$1.19	'
Expired	'	$1.02	$1.25	'
Forfeited	'	$0.99	'	'
Exercised	'	$0.76	$0.37	'
Outstanding	'	'	$1.13	$1.16
Exercisable	'	'	'	$1.18

STOCK_BASED_COMPENSATION_Summa

STOCK BASED COMPENSATION (Summary of Stock Option and Warrant Outstanding) (Details) (Non Qualified Stock Options And Warrants [Member], USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Jun. 30, 2013
	Dec. 31, 2013	Dec. 31, 2012	$0.25 - $1.75 [Member]	$0.25 - $1.75 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'	'
Exercise Prices (Lower Limit)	$0.25	$0.25	$0.25	'
Exercise Prices (Upper Limit)	$1.75	$1.75	$1.75	'
Number Outstanding Currently Exercisable	'	'	'	6,529,123
Weighted Average Remaining Contractual Life	'	'	'2 years 9 months 26 days	'
Exercise Price	'	'	'	$1.18

RELATED_PARTY_Details

RELATED PARTY (Details) (USD $)	Jun. 30, 2013	Dec. 31, 2012
Officer [Member]	'	'
Related Party Transaction [Line Items]	'	'
Travel and office expense accruals	$1,229	$3,356
Two Beneficial Owners [Member]	'	'
Related Party Transaction [Line Items]	'	'
Accrued salaries	42,088	48,650
Related Party [Member]	'	'
Related Party Transaction [Line Items]	'	'
Legal accrual	$5,500	$3,600

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)

1 Months Ended

31-May-12

Apr. 30, 2007

Dec. 31, 2012

Jan. 31, 2014

Mar. 31, 2014

Jan. 31, 2014

CEO [Member]

Warrant Transaction for Consulting Services [Member]

Senior Advisor [Member]

Subsequent Event [Member]

4 Independent Directors [Member]

March 2014 New Employee [Member]

March 2014 New Employee 2 [Member]

March 2014 New Employee 3 [Member]

March 2014 New Employee 4 [Member]

March 2014 New Employee 5 [Member]

CEO [Member]

Warrant Transaction for Consulting Services [Member]

Senior Advisor [Member]

Subsequent Event [Line Items]

Option granted, shares (upper limit)

500,000

125,000

50,000

30,000

75,000

50,000

125,000

30,000

40,000

Option granted, purchase price

$1.30

$0.93

$0.72

$0.92

Option granted, expiration date

'10 years

'5 years

Option granted, value

$613,805

$97,692

$29,440

$23,865

$59,792

$39,862

$98,565

$22,771

$30,362

Vesting immediately

31,256

20,000

25,000

Number of common shares that can be purchased through warrant

900,000

100,000

Exercise of warrants, price per share

0.25

0.92

0.715

Fair value of warrant

$604,416

$66,936

$53,313

Option granted, number of shares vesting in installments

125,000

7,812

10,000

3,750

9,375

6,250

15,625

7,500

10,000

7,500

Frequency of vesting installments

'Quarterly

'Monthly

'Quarterly

'Monthly